data_1pi8_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 1pi8 _Structure_validation_residue.Date_analyzed 2016-10-07 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 7' ' ' ALA . . . . . 0.425 ' H ' ' HB3' ' A' ' 10' ' ' ALA . . . . . . . . 0 N--CA 1.45 -0.466 0 N-CA-C 109.525 -0.546 . . . . 0.0 109.525 . . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 8' ' ' ILE . . . . . 0.444 ' O ' HG23 ' A' ' 12' ' ' VAL . 96.1 mt -52.4 -41.43 35.37 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 115.594 -0.73 . . . . 0.0 110.596 179.988 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . 0.439 ' O ' HG23 ' A' ' 13' ' ' VAL . 68.0 t -64.13 -46.0 94.88 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.315 0 CA-C-N 115.53 -0.759 . . . . 0.0 110.483 179.965 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . 0.425 ' HB3' ' H ' ' A' ' 7' ' ' ALA . . . -56.65 -47.15 80.4 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.602 -0.726 . . . . 0.0 110.569 -179.951 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . 0.779 ' HB3' ' CD1' ' A' ' 15' ' ' ILE . 77.1 mt -59.87 -49.43 77.71 Favored 'General case' 0 C--N 1.312 -1.036 0 CA-C-N 115.674 -0.694 . . . . 0.0 110.563 179.953 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . 0.945 HG12 HD12 ' A' ' 16' ' ' ILE . 68.0 t -55.93 -47.74 79.51 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.458 0 CA-C-N 116.101 -0.499 . . . . 0.0 110.664 -179.97 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . 1.008 ' O ' HG13 ' A' ' 17' ' ' ILE . 75.4 t -58.28 -55.6 21.35 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.547 0 CA-C-N 115.313 -0.858 . . . . 0.0 110.757 179.973 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -69.05 -50.83 45.02 Favored 'General case' 0 C--N 1.318 -0.792 0 CA-C-N 115.365 -0.834 . . . . 0.0 110.739 179.981 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 15' ' ' ILE . . . . . 0.779 ' CD1' ' HB3' ' A' ' 11' ' ' LEU . 96.0 mt -53.82 -44.76 61.06 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.654 0 CA-C-N 115.183 -0.917 . . . . 0.0 110.69 -179.933 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 16' ' ' ILE . . . . . 0.945 HD12 HG12 ' A' ' 12' ' ' VAL . 96.7 mt -71.33 -36.15 60.39 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.697 0 CA-C-N 115.193 -0.912 . . . . 0.0 110.685 -179.984 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 17' ' ' ILE . . . . . 1.008 HG13 ' O ' ' A' ' 13' ' ' VAL . 96.7 mt -67.47 -46.85 82.49 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.795 0 CA-C-N 115.238 -0.892 . . . . 0.0 110.878 179.994 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -66.57 -56.14 12.14 Favored 'General case' 0 C--N 1.307 -1.264 0 CA-C-N 115.415 -0.811 . . . . 0.0 110.811 -179.95 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 19' ' ' ILE . . . . . 0.572 HD12 HG22 ' A' ' 15' ' ' ILE . 96.7 mt -51.84 -48.46 38.96 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.995 0 CA-C-N 115.303 -0.862 . . . . 0.0 110.761 -179.986 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . 0.715 HG23 ' O ' ' A' ' 16' ' ' ILE . 68.2 t -62.66 -46.69 95.74 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.898 0 CA-C-N 114.957 -1.02 . . . . 0.0 110.855 179.989 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . 0.817 HG23 ' O ' ' A' ' 17' ' ' ILE . 74.1 t -66.07 -56.4 14.88 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.114 0 CA-C-N 115.142 -0.935 . . . . 0.0 111.156 179.987 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 22' ' ' TRP . . . . . . . . . . . . . 90.3 t90 -52.29 -33.57 42.75 Favored 'General case' 0 C--N 1.306 -1.318 0 CA-C-N 114.808 -1.087 . . . . 0.0 111.007 179.95 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 48.5 t -69.32 -43.06 74.48 Favored 'General case' 0 N--CA 1.436 -1.139 0 CA-C-N 114.68 -1.145 . . . . 0.0 110.879 -179.94 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . 1.215 ' O ' HG23 ' A' ' 25' ' ' VAL . 96.7 mt -54.5 -46.57 71.4 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.342 0 CA-C-N 114.871 -1.059 . . . . 0.0 111.367 179.96 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . 1.215 HG23 ' O ' ' A' ' 24' ' ' ILE . 58.6 t . . . . . 0 C--N 1.295 -1.804 0 CA-C-N 115.226 -0.897 . . . . 0.0 109.803 -179.952 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 7' ' ' ALA . . . . . 0.423 ' H ' ' HB3' ' A' ' 10' ' ' ALA . . . . . . . . 0 N--CA 1.449 -0.491 0 N-CA-C 109.506 -0.553 . . . . 0.0 109.506 . . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 8' ' ' ILE . . . . . 0.449 ' O ' HG23 ' A' ' 12' ' ' VAL . 96.1 mt -52.4 -41.43 35.37 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 115.594 -0.73 . . . . 0.0 110.596 179.988 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . 0.445 ' O ' HG23 ' A' ' 13' ' ' VAL . 68.0 t -64.13 -46.0 94.88 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.315 0 CA-C-N 115.53 -0.759 . . . . 0.0 110.483 179.965 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . 0.423 ' HB3' ' H ' ' A' ' 7' ' ' ALA . . . -56.65 -47.15 80.4 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.602 -0.726 . . . . 0.0 110.569 -179.951 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . 0.786 ' HB3' ' CD1' ' A' ' 15' ' ' ILE . 77.1 mt -59.87 -49.43 77.71 Favored 'General case' 0 C--N 1.312 -1.036 0 CA-C-N 115.674 -0.694 . . . . 0.0 110.563 179.953 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . 0.944 HG12 HD12 ' A' ' 16' ' ' ILE . 68.0 t -55.93 -47.74 79.51 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.458 0 CA-C-N 116.101 -0.499 . . . . 0.0 110.664 -179.97 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . 1.017 ' O ' HG13 ' A' ' 17' ' ' ILE . 75.4 t -58.28 -55.6 21.35 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.547 0 CA-C-N 115.313 -0.858 . . . . 0.0 110.757 179.973 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -69.05 -50.83 45.02 Favored 'General case' 0 C--N 1.318 -0.792 0 CA-C-N 115.365 -0.834 . . . . 0.0 110.739 179.981 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 15' ' ' ILE . . . . . 0.786 ' CD1' ' HB3' ' A' ' 11' ' ' LEU . 96.0 mt -53.82 -44.76 61.06 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.654 0 CA-C-N 115.183 -0.917 . . . . 0.0 110.69 -179.933 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 16' ' ' ILE . . . . . 0.944 HD12 HG12 ' A' ' 12' ' ' VAL . 96.7 mt -71.33 -36.15 60.39 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.697 0 CA-C-N 115.193 -0.912 . . . . 0.0 110.685 -179.984 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 17' ' ' ILE . . . . . 1.017 HG13 ' O ' ' A' ' 13' ' ' VAL . 96.7 mt -67.47 -46.85 82.49 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.795 0 CA-C-N 115.238 -0.892 . . . . 0.0 110.878 179.994 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -66.57 -56.14 12.14 Favored 'General case' 0 C--N 1.307 -1.264 0 CA-C-N 115.415 -0.811 . . . . 0.0 110.811 -179.95 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 19' ' ' ILE . . . . . 0.589 HD12 HG22 ' A' ' 15' ' ' ILE . 96.7 mt -51.84 -48.46 38.96 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.995 0 CA-C-N 115.303 -0.862 . . . . 0.0 110.761 -179.986 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . 0.731 HG23 ' O ' ' A' ' 16' ' ' ILE . 68.2 t -62.66 -46.69 95.74 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.898 0 CA-C-N 114.957 -1.02 . . . . 0.0 110.855 179.989 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . 0.817 HG23 ' O ' ' A' ' 17' ' ' ILE . 74.1 t -66.07 -56.4 14.88 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.114 0 CA-C-N 115.142 -0.935 . . . . 0.0 111.156 179.987 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 22' ' ' TRP . . . . . . . . . . . . . 90.3 t90 -52.29 -33.57 42.75 Favored 'General case' 0 C--N 1.306 -1.318 0 CA-C-N 114.808 -1.087 . . . . 0.0 111.007 179.95 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 48.5 t -69.32 -43.06 74.48 Favored 'General case' 0 N--CA 1.436 -1.139 0 CA-C-N 114.68 -1.145 . . . . 0.0 110.879 -179.94 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . 1.2 ' O ' HG23 ' A' ' 25' ' ' VAL . 96.7 mt -54.5 -46.57 71.4 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.342 0 CA-C-N 114.871 -1.059 . . . . 0.0 111.367 179.96 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . 1.2 HG23 ' O ' ' A' ' 24' ' ' ILE . 58.6 t . . . . . 0 C--N 1.295 -1.804 0 CA-C-N 115.226 -0.897 . . . . 0.0 109.803 -179.952 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 7' ' ' ALA . . . . . 0.413 ' H ' ' HB3' ' A' ' 10' ' ' ALA . . . . . . . . 0 N--CA 1.449 -0.491 0 N-CA-C 109.506 -0.553 . . . . 0.0 109.506 . . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 8' ' ' ILE . . . . . 0.452 ' O ' HG23 ' A' ' 12' ' ' VAL . 96.1 mt -52.4 -41.43 35.37 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 115.594 -0.73 . . . . 0.0 110.596 179.988 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . 0.431 ' O ' HG23 ' A' ' 13' ' ' VAL . 68.0 t -64.13 -46.0 94.88 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.315 0 CA-C-N 115.53 -0.759 . . . . 0.0 110.483 179.965 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . 0.413 ' HB3' ' H ' ' A' ' 7' ' ' ALA . . . -56.65 -47.15 80.4 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.602 -0.726 . . . . 0.0 110.569 -179.951 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . 0.79 ' HB3' ' CD1' ' A' ' 15' ' ' ILE . 77.1 mt -59.87 -49.43 77.71 Favored 'General case' 0 C--N 1.312 -1.036 0 CA-C-N 115.674 -0.694 . . . . 0.0 110.563 179.953 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . 0.97 HG12 HD12 ' A' ' 16' ' ' ILE . 68.0 t -55.93 -47.74 79.51 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.458 0 CA-C-N 116.101 -0.499 . . . . 0.0 110.664 -179.97 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . 1.02 ' O ' HG13 ' A' ' 17' ' ' ILE . 75.4 t -58.28 -55.6 21.35 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.547 0 CA-C-N 115.313 -0.858 . . . . 0.0 110.757 179.973 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -69.05 -50.83 45.02 Favored 'General case' 0 C--N 1.318 -0.792 0 CA-C-N 115.365 -0.834 . . . . 0.0 110.739 179.981 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 15' ' ' ILE . . . . . 0.79 ' CD1' ' HB3' ' A' ' 11' ' ' LEU . 96.0 mt -53.82 -44.76 61.06 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.654 0 CA-C-N 115.183 -0.917 . . . . 0.0 110.69 -179.933 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 16' ' ' ILE . . . . . 0.97 HD12 HG12 ' A' ' 12' ' ' VAL . 96.7 mt -71.33 -36.15 60.39 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.697 0 CA-C-N 115.193 -0.912 . . . . 0.0 110.685 -179.984 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 17' ' ' ILE . . . . . 1.02 HG13 ' O ' ' A' ' 13' ' ' VAL . 96.7 mt -67.47 -46.85 82.49 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.795 0 CA-C-N 115.238 -0.892 . . . . 0.0 110.878 179.994 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -66.57 -56.14 12.14 Favored 'General case' 0 C--N 1.307 -1.264 0 CA-C-N 115.415 -0.811 . . . . 0.0 110.811 -179.95 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 19' ' ' ILE . . . . . 0.585 HD12 HG22 ' A' ' 15' ' ' ILE . 96.7 mt -51.84 -48.46 38.96 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.995 0 CA-C-N 115.303 -0.862 . . . . 0.0 110.761 -179.986 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . 0.721 HG23 ' O ' ' A' ' 16' ' ' ILE . 68.2 t -62.66 -46.69 95.74 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.898 0 CA-C-N 114.957 -1.02 . . . . 0.0 110.855 179.989 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . 0.803 HG23 ' O ' ' A' ' 17' ' ' ILE . 74.1 t -66.07 -56.4 14.88 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.114 0 CA-C-N 115.142 -0.935 . . . . 0.0 111.156 179.987 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 22' ' ' TRP . . . . . . . . . . . . . 90.3 t90 -52.29 -33.57 42.75 Favored 'General case' 0 C--N 1.306 -1.318 0 CA-C-N 114.808 -1.087 . . . . 0.0 111.007 179.95 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 48.5 t -69.32 -43.06 74.48 Favored 'General case' 0 N--CA 1.436 -1.139 0 CA-C-N 114.68 -1.145 . . . . 0.0 110.879 -179.94 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . 1.229 ' O ' HG23 ' A' ' 25' ' ' VAL . 96.7 mt -54.5 -46.57 71.4 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.342 0 CA-C-N 114.871 -1.059 . . . . 0.0 111.367 179.96 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . 1.229 HG23 ' O ' ' A' ' 24' ' ' ILE . 58.7 t . . . . . 0 C--N 1.295 -1.804 0 CA-C-N 115.226 -0.897 . . . . 0.0 109.794 -179.952 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 7' ' ' ALA . . . . . 0.428 ' H ' ' HB3' ' A' ' 10' ' ' ALA . . . . . . . . 0 N--CA 1.45 -0.466 0 N-CA-C 109.525 -0.546 . . . . 0.0 109.525 . . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 8' ' ' ILE . . . . . 0.441 ' O ' HG23 ' A' ' 12' ' ' VAL . 96.1 mt -52.4 -41.43 35.37 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 115.594 -0.73 . . . . 0.0 110.596 179.988 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . 0.438 ' O ' HG23 ' A' ' 13' ' ' VAL . 68.0 t -64.13 -46.0 94.88 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.315 0 CA-C-N 115.53 -0.759 . . . . 0.0 110.483 179.965 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . 0.428 ' HB3' ' H ' ' A' ' 7' ' ' ALA . . . -56.65 -47.15 80.4 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.602 -0.726 . . . . 0.0 110.569 -179.951 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . 0.784 ' HB3' ' CD1' ' A' ' 15' ' ' ILE . 77.1 mt -59.87 -49.43 77.71 Favored 'General case' 0 C--N 1.312 -1.036 0 CA-C-N 115.674 -0.694 . . . . 0.0 110.563 179.953 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . 0.968 HG12 HD12 ' A' ' 16' ' ' ILE . 68.0 t -55.93 -47.74 79.51 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.458 0 CA-C-N 116.101 -0.499 . . . . 0.0 110.664 -179.97 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . 1.029 ' O ' HG13 ' A' ' 17' ' ' ILE . 75.4 t -58.28 -55.6 21.35 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.547 0 CA-C-N 115.313 -0.858 . . . . 0.0 110.757 179.973 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -69.05 -50.83 45.02 Favored 'General case' 0 C--N 1.318 -0.792 0 CA-C-N 115.365 -0.834 . . . . 0.0 110.739 179.981 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 15' ' ' ILE . . . . . 0.784 ' CD1' ' HB3' ' A' ' 11' ' ' LEU . 96.0 mt -53.82 -44.76 61.06 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.654 0 CA-C-N 115.183 -0.917 . . . . 0.0 110.69 -179.933 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 16' ' ' ILE . . . . . 0.968 HD12 HG12 ' A' ' 12' ' ' VAL . 96.7 mt -71.33 -36.15 60.39 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.697 0 CA-C-N 115.193 -0.912 . . . . 0.0 110.685 -179.984 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 17' ' ' ILE . . . . . 1.029 HG13 ' O ' ' A' ' 13' ' ' VAL . 96.7 mt -67.47 -46.85 82.49 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.795 0 CA-C-N 115.238 -0.892 . . . . 0.0 110.878 179.994 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -66.57 -56.14 12.14 Favored 'General case' 0 C--N 1.307 -1.264 0 CA-C-N 115.415 -0.811 . . . . 0.0 110.811 -179.95 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 19' ' ' ILE . . . . . 0.575 HD12 HG22 ' A' ' 15' ' ' ILE . 96.7 mt -51.84 -48.46 38.96 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.995 0 CA-C-N 115.303 -0.862 . . . . 0.0 110.761 -179.986 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . 0.723 HG23 ' O ' ' A' ' 16' ' ' ILE . 68.2 t -62.66 -46.69 95.74 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.898 0 CA-C-N 114.957 -1.02 . . . . 0.0 110.855 179.989 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . 0.818 HG23 ' O ' ' A' ' 17' ' ' ILE . 74.1 t -66.07 -56.4 14.88 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.114 0 CA-C-N 115.142 -0.935 . . . . 0.0 111.156 179.987 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 22' ' ' TRP . . . . . . . . . . . . . 90.3 t90 -52.29 -33.57 42.75 Favored 'General case' 0 C--N 1.306 -1.318 0 CA-C-N 114.808 -1.087 . . . . 0.0 111.007 179.95 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 48.5 t -69.32 -43.06 74.48 Favored 'General case' 0 N--CA 1.436 -1.139 0 CA-C-N 114.68 -1.145 . . . . 0.0 110.879 -179.94 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . 1.212 ' O ' HG23 ' A' ' 25' ' ' VAL . 96.7 mt -54.5 -46.57 71.4 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.342 0 CA-C-N 114.871 -1.059 . . . . 0.0 111.367 179.96 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . 1.212 HG23 ' O ' ' A' ' 24' ' ' ILE . 58.7 t . . . . . 0 C--N 1.295 -1.804 0 CA-C-N 115.226 -0.897 . . . . 0.0 109.801 -179.952 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . 0.425 ' H ' ' HB3' ' A' ' 10' ' ' ALA . . . . . . . . 0 N--CA 1.45 -0.466 0 N-CA-C 109.525 -0.546 . . . . 0.0 109.525 . . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . 0.444 ' O ' HG23 ' A' ' 12' ' ' VAL . 96.1 mt -52.4 -41.43 35.37 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 115.594 -0.73 . . . . 0.0 110.596 179.988 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . 0.439 ' O ' HG23 ' A' ' 13' ' ' VAL . 68.0 t -64.13 -46.0 94.88 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.315 0 CA-C-N 115.53 -0.759 . . . . 0.0 110.483 179.965 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . 0.425 ' HB3' ' H ' ' A' ' 7' ' ' ALA . . . -56.65 -47.15 80.4 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.602 -0.726 . . . . 0.0 110.569 -179.951 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . 0.779 ' HB3' ' CD1' ' A' ' 15' ' ' ILE . 77.1 mt -59.87 -49.43 77.71 Favored 'General case' 0 C--N 1.312 -1.036 0 CA-C-N 115.674 -0.694 . . . . 0.0 110.563 179.953 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . 0.945 HG12 HD12 ' A' ' 16' ' ' ILE . 68.0 t -55.93 -47.74 79.51 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.458 0 CA-C-N 116.101 -0.499 . . . . 0.0 110.664 -179.97 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . 1.008 ' O ' HG13 ' A' ' 17' ' ' ILE . 75.4 t -58.28 -55.6 21.35 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.547 0 CA-C-N 115.313 -0.858 . . . . 0.0 110.757 179.973 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -69.05 -50.83 45.02 Favored 'General case' 0 C--N 1.318 -0.792 0 CA-C-N 115.365 -0.834 . . . . 0.0 110.739 179.981 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . 0.779 ' CD1' ' HB3' ' A' ' 11' ' ' LEU . 96.0 mt -53.82 -44.76 61.06 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.654 0 CA-C-N 115.183 -0.917 . . . . 0.0 110.69 -179.933 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 16' ' ' ILE . . . . . 0.945 HD12 HG12 ' A' ' 12' ' ' VAL . 96.7 mt -71.33 -36.15 60.39 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.697 0 CA-C-N 115.193 -0.912 . . . . 0.0 110.685 -179.984 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 17' ' ' ILE . . . . . 1.008 HG13 ' O ' ' A' ' 13' ' ' VAL . 96.7 mt -67.47 -46.85 82.49 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.795 0 CA-C-N 115.238 -0.892 . . . . 0.0 110.878 179.994 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -66.57 -56.14 12.14 Favored 'General case' 0 C--N 1.307 -1.264 0 CA-C-N 115.415 -0.811 . . . . 0.0 110.811 -179.95 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' ILE . . . . . 0.572 HD12 HG22 ' A' ' 15' ' ' ILE . 96.7 mt -51.84 -48.46 38.96 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.995 0 CA-C-N 115.303 -0.862 . . . . 0.0 110.761 -179.986 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . 0.715 HG23 ' O ' ' A' ' 16' ' ' ILE . 68.2 t -62.66 -46.69 95.74 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.898 0 CA-C-N 114.957 -1.02 . . . . 0.0 110.855 179.989 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . 0.817 HG23 ' O ' ' A' ' 17' ' ' ILE . 74.1 t -66.07 -56.4 14.88 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.114 0 CA-C-N 115.142 -0.935 . . . . 0.0 111.156 179.987 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 22' ' ' TRP . . . . . . . . . . . . . 90.3 t90 -52.29 -33.57 42.75 Favored 'General case' 0 C--N 1.306 -1.318 0 CA-C-N 114.808 -1.087 . . . . 0.0 111.007 179.95 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 48.5 t -69.32 -43.06 74.48 Favored 'General case' 0 N--CA 1.436 -1.139 0 CA-C-N 114.68 -1.145 . . . . 0.0 110.879 -179.94 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . 1.215 ' O ' HG23 ' A' ' 25' ' ' VAL . 96.7 mt -54.5 -46.57 71.4 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.342 0 CA-C-N 114.871 -1.059 . . . . 0.0 111.367 179.96 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . 1.215 HG23 ' O ' ' A' ' 24' ' ' ILE . 58.6 t . . . . . 0 C--N 1.295 -1.804 0 CA-C-N 115.226 -0.897 . . . . 0.0 109.803 -179.952 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . 0.423 ' H ' ' HB3' ' A' ' 10' ' ' ALA . . . . . . . . 0 N--CA 1.449 -0.491 0 N-CA-C 109.506 -0.553 . . . . 0.0 109.506 . . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . 0.449 ' O ' HG23 ' A' ' 12' ' ' VAL . 96.1 mt -52.4 -41.43 35.37 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 115.594 -0.73 . . . . 0.0 110.596 179.988 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . 0.445 ' O ' HG23 ' A' ' 13' ' ' VAL . 68.0 t -64.13 -46.0 94.88 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.315 0 CA-C-N 115.53 -0.759 . . . . 0.0 110.483 179.965 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . 0.423 ' HB3' ' H ' ' A' ' 7' ' ' ALA . . . -56.65 -47.15 80.4 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.602 -0.726 . . . . 0.0 110.569 -179.951 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . 0.786 ' HB3' ' CD1' ' A' ' 15' ' ' ILE . 77.1 mt -59.87 -49.43 77.71 Favored 'General case' 0 C--N 1.312 -1.036 0 CA-C-N 115.674 -0.694 . . . . 0.0 110.563 179.953 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . 0.944 HG12 HD12 ' A' ' 16' ' ' ILE . 68.0 t -55.93 -47.74 79.51 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.458 0 CA-C-N 116.101 -0.499 . . . . 0.0 110.664 -179.97 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . 1.017 ' O ' HG13 ' A' ' 17' ' ' ILE . 75.4 t -58.28 -55.6 21.35 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.547 0 CA-C-N 115.313 -0.858 . . . . 0.0 110.757 179.973 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -69.05 -50.83 45.02 Favored 'General case' 0 C--N 1.318 -0.792 0 CA-C-N 115.365 -0.834 . . . . 0.0 110.739 179.981 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . 0.786 ' CD1' ' HB3' ' A' ' 11' ' ' LEU . 96.0 mt -53.82 -44.76 61.06 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.654 0 CA-C-N 115.183 -0.917 . . . . 0.0 110.69 -179.933 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 16' ' ' ILE . . . . . 0.944 HD12 HG12 ' A' ' 12' ' ' VAL . 96.7 mt -71.33 -36.15 60.39 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.697 0 CA-C-N 115.193 -0.912 . . . . 0.0 110.685 -179.984 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 17' ' ' ILE . . . . . 1.017 HG13 ' O ' ' A' ' 13' ' ' VAL . 96.7 mt -67.47 -46.85 82.49 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.795 0 CA-C-N 115.238 -0.892 . . . . 0.0 110.878 179.994 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -66.57 -56.14 12.14 Favored 'General case' 0 C--N 1.307 -1.264 0 CA-C-N 115.415 -0.811 . . . . 0.0 110.811 -179.95 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 19' ' ' ILE . . . . . 0.589 HD12 HG22 ' A' ' 15' ' ' ILE . 96.7 mt -51.84 -48.46 38.96 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.995 0 CA-C-N 115.303 -0.862 . . . . 0.0 110.761 -179.986 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . 0.731 HG23 ' O ' ' A' ' 16' ' ' ILE . 68.2 t -62.66 -46.69 95.74 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.898 0 CA-C-N 114.957 -1.02 . . . . 0.0 110.855 179.989 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . 0.817 HG23 ' O ' ' A' ' 17' ' ' ILE . 74.1 t -66.07 -56.4 14.88 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.114 0 CA-C-N 115.142 -0.935 . . . . 0.0 111.156 179.987 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 22' ' ' TRP . . . . . . . . . . . . . 90.3 t90 -52.29 -33.57 42.75 Favored 'General case' 0 C--N 1.306 -1.318 0 CA-C-N 114.808 -1.087 . . . . 0.0 111.007 179.95 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 48.5 t -69.32 -43.06 74.48 Favored 'General case' 0 N--CA 1.436 -1.139 0 CA-C-N 114.68 -1.145 . . . . 0.0 110.879 -179.94 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . 1.2 ' O ' HG23 ' A' ' 25' ' ' VAL . 96.7 mt -54.5 -46.57 71.4 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.342 0 CA-C-N 114.871 -1.059 . . . . 0.0 111.367 179.96 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . 1.2 HG23 ' O ' ' A' ' 24' ' ' ILE . 58.6 t . . . . . 0 C--N 1.295 -1.804 0 CA-C-N 115.226 -0.897 . . . . 0.0 109.803 -179.952 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . 0.413 ' H ' ' HB3' ' A' ' 10' ' ' ALA . . . . . . . . 0 N--CA 1.449 -0.491 0 N-CA-C 109.506 -0.553 . . . . 0.0 109.506 . . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . 0.452 ' O ' HG23 ' A' ' 12' ' ' VAL . 96.1 mt -52.4 -41.43 35.37 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 115.594 -0.73 . . . . 0.0 110.596 179.988 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . 0.431 ' O ' HG23 ' A' ' 13' ' ' VAL . 68.0 t -64.13 -46.0 94.88 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.315 0 CA-C-N 115.53 -0.759 . . . . 0.0 110.483 179.965 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . 0.413 ' HB3' ' H ' ' A' ' 7' ' ' ALA . . . -56.65 -47.15 80.4 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.602 -0.726 . . . . 0.0 110.569 -179.951 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . 0.79 ' HB3' ' CD1' ' A' ' 15' ' ' ILE . 77.1 mt -59.87 -49.43 77.71 Favored 'General case' 0 C--N 1.312 -1.036 0 CA-C-N 115.674 -0.694 . . . . 0.0 110.563 179.953 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . 0.97 HG12 HD12 ' A' ' 16' ' ' ILE . 68.0 t -55.93 -47.74 79.51 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.458 0 CA-C-N 116.101 -0.499 . . . . 0.0 110.664 -179.97 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . 1.02 ' O ' HG13 ' A' ' 17' ' ' ILE . 75.4 t -58.28 -55.6 21.35 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.547 0 CA-C-N 115.313 -0.858 . . . . 0.0 110.757 179.973 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -69.05 -50.83 45.02 Favored 'General case' 0 C--N 1.318 -0.792 0 CA-C-N 115.365 -0.834 . . . . 0.0 110.739 179.981 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . 0.79 ' CD1' ' HB3' ' A' ' 11' ' ' LEU . 96.0 mt -53.82 -44.76 61.06 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.654 0 CA-C-N 115.183 -0.917 . . . . 0.0 110.69 -179.933 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 16' ' ' ILE . . . . . 0.97 HD12 HG12 ' A' ' 12' ' ' VAL . 96.7 mt -71.33 -36.15 60.39 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.697 0 CA-C-N 115.193 -0.912 . . . . 0.0 110.685 -179.984 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 17' ' ' ILE . . . . . 1.02 HG13 ' O ' ' A' ' 13' ' ' VAL . 96.7 mt -67.47 -46.85 82.49 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.795 0 CA-C-N 115.238 -0.892 . . . . 0.0 110.878 179.994 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -66.57 -56.14 12.14 Favored 'General case' 0 C--N 1.307 -1.264 0 CA-C-N 115.415 -0.811 . . . . 0.0 110.811 -179.95 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 19' ' ' ILE . . . . . 0.585 HD12 HG22 ' A' ' 15' ' ' ILE . 96.7 mt -51.84 -48.46 38.96 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.995 0 CA-C-N 115.303 -0.862 . . . . 0.0 110.761 -179.986 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . 0.721 HG23 ' O ' ' A' ' 16' ' ' ILE . 68.2 t -62.66 -46.69 95.74 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.898 0 CA-C-N 114.957 -1.02 . . . . 0.0 110.855 179.989 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . 0.803 HG23 ' O ' ' A' ' 17' ' ' ILE . 74.1 t -66.07 -56.4 14.88 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.114 0 CA-C-N 115.142 -0.935 . . . . 0.0 111.156 179.987 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 22' ' ' TRP . . . . . . . . . . . . . 90.3 t90 -52.29 -33.57 42.75 Favored 'General case' 0 C--N 1.306 -1.318 0 CA-C-N 114.808 -1.087 . . . . 0.0 111.007 179.95 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 48.5 t -69.32 -43.06 74.48 Favored 'General case' 0 N--CA 1.436 -1.139 0 CA-C-N 114.68 -1.145 . . . . 0.0 110.879 -179.94 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . 1.229 ' O ' HG23 ' A' ' 25' ' ' VAL . 96.7 mt -54.5 -46.57 71.4 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.342 0 CA-C-N 114.871 -1.059 . . . . 0.0 111.367 179.96 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . 1.229 HG23 ' O ' ' A' ' 24' ' ' ILE . 58.7 t . . . . . 0 C--N 1.295 -1.804 0 CA-C-N 115.226 -0.897 . . . . 0.0 109.794 -179.952 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . 0.428 ' H ' ' HB3' ' A' ' 10' ' ' ALA . . . . . . . . 0 N--CA 1.45 -0.466 0 N-CA-C 109.525 -0.546 . . . . 0.0 109.525 . . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . 0.441 ' O ' HG23 ' A' ' 12' ' ' VAL . 96.1 mt -52.4 -41.43 35.37 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 115.594 -0.73 . . . . 0.0 110.596 179.988 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . 0.438 ' O ' HG23 ' A' ' 13' ' ' VAL . 68.0 t -64.13 -46.0 94.88 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.315 0 CA-C-N 115.53 -0.759 . . . . 0.0 110.483 179.965 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . 0.428 ' HB3' ' H ' ' A' ' 7' ' ' ALA . . . -56.65 -47.15 80.4 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.602 -0.726 . . . . 0.0 110.569 -179.951 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . 0.784 ' HB3' ' CD1' ' A' ' 15' ' ' ILE . 77.1 mt -59.87 -49.43 77.71 Favored 'General case' 0 C--N 1.312 -1.036 0 CA-C-N 115.674 -0.694 . . . . 0.0 110.563 179.953 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . 0.968 HG12 HD12 ' A' ' 16' ' ' ILE . 68.0 t -55.93 -47.74 79.51 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.458 0 CA-C-N 116.101 -0.499 . . . . 0.0 110.664 -179.97 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . 1.029 ' O ' HG13 ' A' ' 17' ' ' ILE . 75.4 t -58.28 -55.6 21.35 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.547 0 CA-C-N 115.313 -0.858 . . . . 0.0 110.757 179.973 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -69.05 -50.83 45.02 Favored 'General case' 0 C--N 1.318 -0.792 0 CA-C-N 115.365 -0.834 . . . . 0.0 110.739 179.981 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . 0.784 ' CD1' ' HB3' ' A' ' 11' ' ' LEU . 96.0 mt -53.82 -44.76 61.06 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.654 0 CA-C-N 115.183 -0.917 . . . . 0.0 110.69 -179.933 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 16' ' ' ILE . . . . . 0.968 HD12 HG12 ' A' ' 12' ' ' VAL . 96.7 mt -71.33 -36.15 60.39 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.697 0 CA-C-N 115.193 -0.912 . . . . 0.0 110.685 -179.984 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 17' ' ' ILE . . . . . 1.029 HG13 ' O ' ' A' ' 13' ' ' VAL . 96.7 mt -67.47 -46.85 82.49 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.795 0 CA-C-N 115.238 -0.892 . . . . 0.0 110.878 179.994 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -66.57 -56.14 12.14 Favored 'General case' 0 C--N 1.307 -1.264 0 CA-C-N 115.415 -0.811 . . . . 0.0 110.811 -179.95 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 19' ' ' ILE . . . . . 0.575 HD12 HG22 ' A' ' 15' ' ' ILE . 96.7 mt -51.84 -48.46 38.96 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.995 0 CA-C-N 115.303 -0.862 . . . . 0.0 110.761 -179.986 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . 0.723 HG23 ' O ' ' A' ' 16' ' ' ILE . 68.2 t -62.66 -46.69 95.74 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.898 0 CA-C-N 114.957 -1.02 . . . . 0.0 110.855 179.989 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . 0.818 HG23 ' O ' ' A' ' 17' ' ' ILE . 74.1 t -66.07 -56.4 14.88 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.114 0 CA-C-N 115.142 -0.935 . . . . 0.0 111.156 179.987 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 22' ' ' TRP . . . . . . . . . . . . . 90.3 t90 -52.29 -33.57 42.75 Favored 'General case' 0 C--N 1.306 -1.318 0 CA-C-N 114.808 -1.087 . . . . 0.0 111.007 179.95 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 48.5 t -69.32 -43.06 74.48 Favored 'General case' 0 N--CA 1.436 -1.139 0 CA-C-N 114.68 -1.145 . . . . 0.0 110.879 -179.94 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . 1.212 ' O ' HG23 ' A' ' 25' ' ' VAL . 96.7 mt -54.5 -46.57 71.4 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.342 0 CA-C-N 114.871 -1.059 . . . . 0.0 111.367 179.96 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . 1.212 HG23 ' O ' ' A' ' 24' ' ' ILE . 58.7 t . . . . . 0 C--N 1.295 -1.804 0 CA-C-N 115.226 -0.897 . . . . 0.0 109.801 -179.952 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.466 0 N-CA-C 109.525 -0.546 . . . . 0.0 109.525 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 8' ' ' ILE . . . . . 0.446 ' O ' HG23 ' A' ' 12' ' ' VAL . 96.1 mt -52.4 -41.43 35.37 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 115.594 -0.73 . . . . 0.0 110.596 179.988 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 9' ' ' VAL . . . . . 0.441 ' O ' HG23 ' A' ' 13' ' ' VAL . 68.0 t -64.13 -46.0 94.88 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.315 0 CA-C-N 115.53 -0.759 . . . . 0.0 110.483 179.965 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -56.65 -47.15 80.4 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.602 -0.726 . . . . 0.0 110.569 -179.951 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 11' ' ' LEU . . . . . 0.777 ' HB3' ' CD1' ' A' ' 15' ' ' ILE . 77.1 mt -59.87 -49.43 77.71 Favored 'General case' 0 C--N 1.312 -1.036 0 CA-C-N 115.674 -0.694 . . . . 0.0 110.563 179.953 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 12' ' ' VAL . . . . . 0.939 HG12 HD12 ' A' ' 16' ' ' ILE . 68.0 t -55.93 -47.74 79.51 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.458 0 CA-C-N 116.101 -0.499 . . . . 0.0 110.664 -179.97 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 13' ' ' VAL . . . . . 0.988 ' O ' HG13 ' A' ' 17' ' ' ILE . 75.4 t -58.28 -55.6 21.35 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.547 0 CA-C-N 115.313 -0.858 . . . . 0.0 110.757 179.973 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -69.05 -50.83 45.02 Favored 'General case' 0 C--N 1.318 -0.792 0 CA-C-N 115.365 -0.834 . . . . 0.0 110.739 179.981 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 15' ' ' ILE . . . . . 0.777 ' CD1' ' HB3' ' A' ' 11' ' ' LEU . 96.0 mt -53.82 -44.76 61.06 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.654 0 CA-C-N 115.183 -0.917 . . . . 0.0 110.69 -179.933 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 16' ' ' ILE . . . . . 0.939 HD12 HG12 ' A' ' 12' ' ' VAL . 96.7 mt -71.33 -36.15 60.39 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.697 0 CA-C-N 115.193 -0.912 . . . . 0.0 110.685 -179.984 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 17' ' ' ILE . . . . . 0.988 HG13 ' O ' ' A' ' 13' ' ' VAL . 96.7 mt -67.47 -46.85 82.49 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.795 0 CA-C-N 115.238 -0.892 . . . . 0.0 110.878 179.994 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -66.57 -56.14 12.14 Favored 'General case' 0 C--N 1.307 -1.264 0 CA-C-N 115.415 -0.811 . . . . 0.0 110.811 -179.95 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 19' ' ' ILE . . . . . 0.57 HD12 HG22 ' A' ' 15' ' ' ILE . 96.7 mt -51.84 -48.46 38.96 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.995 0 CA-C-N 115.303 -0.862 . . . . 0.0 110.761 -179.986 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 20' ' ' VAL . . . . . 0.72 HG23 ' O ' ' A' ' 16' ' ' ILE . 68.2 t -62.66 -46.69 95.74 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.898 0 CA-C-N 114.957 -1.02 . . . . 0.0 110.855 179.989 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 21' ' ' VAL . . . . . 0.823 HG23 ' O ' ' A' ' 17' ' ' ILE . 74.1 t -66.07 -56.4 14.88 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.114 0 CA-C-N 115.142 -0.935 . . . . 0.0 111.156 179.987 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 22' ' ' TRP . . . . . . . . . . . . . 90.3 t90 -52.29 -33.57 42.75 Favored 'General case' 0 C--N 1.306 -1.318 0 CA-C-N 114.808 -1.087 . . . . 0.0 111.007 179.95 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 48.5 t -69.32 -43.06 74.48 Favored 'General case' 0 N--CA 1.436 -1.139 0 CA-C-N 114.68 -1.145 . . . . 0.0 110.879 -179.94 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 24' ' ' ILE . . . . . 1.215 ' O ' HG23 ' A' ' 25' ' ' VAL . 96.7 mt -54.5 -46.57 71.4 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.342 0 CA-C-N 114.871 -1.059 . . . . 0.0 111.367 179.96 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 25' ' ' VAL . . . . . 1.215 HG23 ' O ' ' A' ' 24' ' ' ILE . 58.6 t . . . . . 0 C--N 1.295 -1.804 0 CA-C-N 115.226 -0.897 . . . . 0.0 109.803 -179.952 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.449 -0.491 0 N-CA-C 109.506 -0.553 . . . . 0.0 109.506 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 8' ' ' ILE . . . . . 0.452 ' O ' HG23 ' A' ' 12' ' ' VAL . 96.1 mt -52.4 -41.43 35.37 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 115.594 -0.73 . . . . 0.0 110.596 179.988 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 9' ' ' VAL . . . . . 0.449 ' O ' HG23 ' A' ' 13' ' ' VAL . 68.0 t -64.13 -46.0 94.88 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.315 0 CA-C-N 115.53 -0.759 . . . . 0.0 110.483 179.965 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -56.65 -47.15 80.4 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.602 -0.726 . . . . 0.0 110.569 -179.951 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 11' ' ' LEU . . . . . 0.783 ' HB3' ' CD1' ' A' ' 15' ' ' ILE . 77.1 mt -59.87 -49.43 77.71 Favored 'General case' 0 C--N 1.312 -1.036 0 CA-C-N 115.674 -0.694 . . . . 0.0 110.563 179.953 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 12' ' ' VAL . . . . . 0.938 HG12 HD12 ' A' ' 16' ' ' ILE . 68.0 t -55.93 -47.74 79.51 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.458 0 CA-C-N 116.101 -0.499 . . . . 0.0 110.664 -179.97 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 13' ' ' VAL . . . . . 1.003 ' O ' HG13 ' A' ' 17' ' ' ILE . 75.4 t -58.28 -55.6 21.35 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.547 0 CA-C-N 115.313 -0.858 . . . . 0.0 110.757 179.973 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -69.05 -50.83 45.02 Favored 'General case' 0 C--N 1.318 -0.792 0 CA-C-N 115.365 -0.834 . . . . 0.0 110.739 179.981 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 15' ' ' ILE . . . . . 0.783 ' CD1' ' HB3' ' A' ' 11' ' ' LEU . 96.0 mt -53.82 -44.76 61.06 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.654 0 CA-C-N 115.183 -0.917 . . . . 0.0 110.69 -179.933 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 16' ' ' ILE . . . . . 0.938 HD12 HG12 ' A' ' 12' ' ' VAL . 96.7 mt -71.33 -36.15 60.39 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.697 0 CA-C-N 115.193 -0.912 . . . . 0.0 110.685 -179.984 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 17' ' ' ILE . . . . . 1.003 HG13 ' O ' ' A' ' 13' ' ' VAL . 96.7 mt -67.47 -46.85 82.49 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.795 0 CA-C-N 115.238 -0.892 . . . . 0.0 110.878 179.994 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -66.57 -56.14 12.14 Favored 'General case' 0 C--N 1.307 -1.264 0 CA-C-N 115.415 -0.811 . . . . 0.0 110.811 -179.95 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 19' ' ' ILE . . . . . 0.587 HD12 HG22 ' A' ' 15' ' ' ILE . 96.7 mt -51.84 -48.46 38.96 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.995 0 CA-C-N 115.303 -0.862 . . . . 0.0 110.761 -179.986 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 20' ' ' VAL . . . . . 0.736 HG23 ' O ' ' A' ' 16' ' ' ILE . 68.2 t -62.66 -46.69 95.74 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.898 0 CA-C-N 114.957 -1.02 . . . . 0.0 110.855 179.989 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 21' ' ' VAL . . . . . 0.824 HG23 ' O ' ' A' ' 17' ' ' ILE . 74.1 t -66.07 -56.4 14.88 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.114 0 CA-C-N 115.142 -0.935 . . . . 0.0 111.156 179.987 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 22' ' ' TRP . . . . . . . . . . . . . 90.3 t90 -52.29 -33.57 42.75 Favored 'General case' 0 C--N 1.306 -1.318 0 CA-C-N 114.808 -1.087 . . . . 0.0 111.007 179.95 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 48.5 t -69.32 -43.06 74.48 Favored 'General case' 0 N--CA 1.436 -1.139 0 CA-C-N 114.68 -1.145 . . . . 0.0 110.879 -179.94 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 24' ' ' ILE . . . . . 1.201 ' O ' HG23 ' A' ' 25' ' ' VAL . 96.7 mt -54.5 -46.57 71.4 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.342 0 CA-C-N 114.871 -1.059 . . . . 0.0 111.367 179.96 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 25' ' ' VAL . . . . . 1.201 HG23 ' O ' ' A' ' 24' ' ' ILE . 58.6 t . . . . . 0 C--N 1.295 -1.804 0 CA-C-N 115.226 -0.897 . . . . 0.0 109.803 -179.952 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.449 -0.491 0 N-CA-C 109.506 -0.553 . . . . 0.0 109.506 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 8' ' ' ILE . . . . . 0.456 ' O ' HG23 ' A' ' 12' ' ' VAL . 96.1 mt -52.4 -41.43 35.37 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 115.594 -0.73 . . . . 0.0 110.596 179.988 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 9' ' ' VAL . . . . . 0.433 ' O ' HG23 ' A' ' 13' ' ' VAL . 68.0 t -64.13 -46.0 94.88 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.315 0 CA-C-N 115.53 -0.759 . . . . 0.0 110.483 179.965 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -56.65 -47.15 80.4 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.602 -0.726 . . . . 0.0 110.569 -179.951 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 11' ' ' LEU . . . . . 0.787 ' HB3' ' CD1' ' A' ' 15' ' ' ILE . 77.1 mt -59.87 -49.43 77.71 Favored 'General case' 0 C--N 1.312 -1.036 0 CA-C-N 115.674 -0.694 . . . . 0.0 110.563 179.953 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 12' ' ' VAL . . . . . 0.965 HG12 HD12 ' A' ' 16' ' ' ILE . 68.0 t -55.93 -47.74 79.51 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.458 0 CA-C-N 116.101 -0.499 . . . . 0.0 110.664 -179.97 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 13' ' ' VAL . . . . . 1.0 ' O ' HG13 ' A' ' 17' ' ' ILE . 75.4 t -58.28 -55.6 21.35 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.547 0 CA-C-N 115.313 -0.858 . . . . 0.0 110.757 179.973 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -69.05 -50.83 45.02 Favored 'General case' 0 C--N 1.318 -0.792 0 CA-C-N 115.365 -0.834 . . . . 0.0 110.739 179.981 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 15' ' ' ILE . . . . . 0.787 ' CD1' ' HB3' ' A' ' 11' ' ' LEU . 96.0 mt -53.82 -44.76 61.06 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.654 0 CA-C-N 115.183 -0.917 . . . . 0.0 110.69 -179.933 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 16' ' ' ILE . . . . . 0.965 HD12 HG12 ' A' ' 12' ' ' VAL . 96.7 mt -71.33 -36.15 60.39 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.697 0 CA-C-N 115.193 -0.912 . . . . 0.0 110.685 -179.984 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 17' ' ' ILE . . . . . 1.0 HG13 ' O ' ' A' ' 13' ' ' VAL . 96.7 mt -67.47 -46.85 82.49 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.795 0 CA-C-N 115.238 -0.892 . . . . 0.0 110.878 179.994 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -66.57 -56.14 12.14 Favored 'General case' 0 C--N 1.307 -1.264 0 CA-C-N 115.415 -0.811 . . . . 0.0 110.811 -179.95 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 19' ' ' ILE . . . . . 0.583 HD12 HG22 ' A' ' 15' ' ' ILE . 96.7 mt -51.84 -48.46 38.96 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.995 0 CA-C-N 115.303 -0.862 . . . . 0.0 110.761 -179.986 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 20' ' ' VAL . . . . . 0.725 HG23 ' O ' ' A' ' 16' ' ' ILE . 68.2 t -62.66 -46.69 95.74 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.898 0 CA-C-N 114.957 -1.02 . . . . 0.0 110.855 179.989 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 21' ' ' VAL . . . . . 0.809 HG23 ' O ' ' A' ' 17' ' ' ILE . 74.1 t -66.07 -56.4 14.88 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.114 0 CA-C-N 115.142 -0.935 . . . . 0.0 111.156 179.987 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 22' ' ' TRP . . . . . . . . . . . . . 90.3 t90 -52.29 -33.57 42.75 Favored 'General case' 0 C--N 1.306 -1.318 0 CA-C-N 114.808 -1.087 . . . . 0.0 111.007 179.95 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 48.5 t -69.32 -43.06 74.48 Favored 'General case' 0 N--CA 1.436 -1.139 0 CA-C-N 114.68 -1.145 . . . . 0.0 110.879 -179.94 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 24' ' ' ILE . . . . . 1.229 ' O ' HG23 ' A' ' 25' ' ' VAL . 96.7 mt -54.5 -46.57 71.4 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.342 0 CA-C-N 114.871 -1.059 . . . . 0.0 111.367 179.96 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 25' ' ' VAL . . . . . 1.229 HG23 ' O ' ' A' ' 24' ' ' ILE . 58.7 t . . . . . 0 C--N 1.295 -1.804 0 CA-C-N 115.226 -0.897 . . . . 0.0 109.794 -179.952 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.466 0 N-CA-C 109.525 -0.546 . . . . 0.0 109.525 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 8' ' ' ILE . . . . . 0.443 ' O ' HG23 ' A' ' 12' ' ' VAL . 96.1 mt -52.4 -41.43 35.37 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 115.594 -0.73 . . . . 0.0 110.596 179.988 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 9' ' ' VAL . . . . . 0.441 ' O ' HG23 ' A' ' 13' ' ' VAL . 68.0 t -64.13 -46.0 94.88 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.315 0 CA-C-N 115.53 -0.759 . . . . 0.0 110.483 179.965 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -56.65 -47.15 80.4 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.602 -0.726 . . . . 0.0 110.569 -179.951 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 11' ' ' LEU . . . . . 0.782 ' HB3' ' CD1' ' A' ' 15' ' ' ILE . 77.1 mt -59.87 -49.43 77.71 Favored 'General case' 0 C--N 1.312 -1.036 0 CA-C-N 115.674 -0.694 . . . . 0.0 110.563 179.953 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 12' ' ' VAL . . . . . 0.963 HG12 HD12 ' A' ' 16' ' ' ILE . 68.0 t -55.93 -47.74 79.51 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.458 0 CA-C-N 116.101 -0.499 . . . . 0.0 110.664 -179.97 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 13' ' ' VAL . . . . . 1.01 ' O ' HG13 ' A' ' 17' ' ' ILE . 75.4 t -58.28 -55.6 21.35 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.547 0 CA-C-N 115.313 -0.858 . . . . 0.0 110.757 179.973 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -69.05 -50.83 45.02 Favored 'General case' 0 C--N 1.318 -0.792 0 CA-C-N 115.365 -0.834 . . . . 0.0 110.739 179.981 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 15' ' ' ILE . . . . . 0.782 ' CD1' ' HB3' ' A' ' 11' ' ' LEU . 96.0 mt -53.82 -44.76 61.06 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.654 0 CA-C-N 115.183 -0.917 . . . . 0.0 110.69 -179.933 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 16' ' ' ILE . . . . . 0.963 HD12 HG12 ' A' ' 12' ' ' VAL . 96.7 mt -71.33 -36.15 60.39 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.697 0 CA-C-N 115.193 -0.912 . . . . 0.0 110.685 -179.984 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 17' ' ' ILE . . . . . 1.01 HG13 ' O ' ' A' ' 13' ' ' VAL . 96.7 mt -67.47 -46.85 82.49 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.795 0 CA-C-N 115.238 -0.892 . . . . 0.0 110.878 179.994 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -66.57 -56.14 12.14 Favored 'General case' 0 C--N 1.307 -1.264 0 CA-C-N 115.415 -0.811 . . . . 0.0 110.811 -179.95 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 19' ' ' ILE . . . . . 0.572 HD12 HG22 ' A' ' 15' ' ' ILE . 96.7 mt -51.84 -48.46 38.96 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.995 0 CA-C-N 115.303 -0.862 . . . . 0.0 110.761 -179.986 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 20' ' ' VAL . . . . . 0.729 HG23 ' O ' ' A' ' 16' ' ' ILE . 68.2 t -62.66 -46.69 95.74 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.898 0 CA-C-N 114.957 -1.02 . . . . 0.0 110.855 179.989 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 21' ' ' VAL . . . . . 0.822 HG23 ' O ' ' A' ' 17' ' ' ILE . 74.1 t -66.07 -56.4 14.88 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.114 0 CA-C-N 115.142 -0.935 . . . . 0.0 111.156 179.987 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 22' ' ' TRP . . . . . . . . . . . . . 90.3 t90 -52.29 -33.57 42.75 Favored 'General case' 0 C--N 1.306 -1.318 0 CA-C-N 114.808 -1.087 . . . . 0.0 111.007 179.95 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 48.5 t -69.32 -43.06 74.48 Favored 'General case' 0 N--CA 1.436 -1.139 0 CA-C-N 114.68 -1.145 . . . . 0.0 110.879 -179.94 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 24' ' ' ILE . . . . . 1.211 ' O ' HG23 ' A' ' 25' ' ' VAL . 96.7 mt -54.5 -46.57 71.4 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.342 0 CA-C-N 114.871 -1.059 . . . . 0.0 111.367 179.96 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 25' ' ' VAL . . . . . 1.211 HG23 ' O ' ' A' ' 24' ' ' ILE . 58.7 t . . . . . 0 C--N 1.295 -1.804 0 CA-C-N 115.226 -0.897 . . . . 0.0 109.801 -179.952 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.466 0 N-CA-C 109.525 -0.546 . . . . 0.0 109.525 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 8' ' ' ILE . . . . . 0.446 ' O ' HG23 ' A' ' 12' ' ' VAL . 96.1 mt -52.4 -41.43 35.37 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 115.594 -0.73 . . . . 0.0 110.596 179.988 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 9' ' ' VAL . . . . . 0.441 ' O ' HG23 ' A' ' 13' ' ' VAL . 68.0 t -64.13 -46.0 94.88 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.315 0 CA-C-N 115.53 -0.759 . . . . 0.0 110.483 179.965 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -56.65 -47.15 80.4 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.602 -0.726 . . . . 0.0 110.569 -179.951 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 11' ' ' LEU . . . . . 0.777 ' HB3' ' CD1' ' A' ' 15' ' ' ILE . 77.1 mt -59.87 -49.43 77.71 Favored 'General case' 0 C--N 1.312 -1.036 0 CA-C-N 115.674 -0.694 . . . . 0.0 110.563 179.953 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 12' ' ' VAL . . . . . 0.939 HG12 HD12 ' A' ' 16' ' ' ILE . 68.0 t -55.93 -47.74 79.51 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.458 0 CA-C-N 116.101 -0.499 . . . . 0.0 110.664 -179.97 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 13' ' ' VAL . . . . . 0.988 ' O ' HG13 ' A' ' 17' ' ' ILE . 75.4 t -58.28 -55.6 21.35 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.547 0 CA-C-N 115.313 -0.858 . . . . 0.0 110.757 179.973 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -69.05 -50.83 45.02 Favored 'General case' 0 C--N 1.318 -0.792 0 CA-C-N 115.365 -0.834 . . . . 0.0 110.739 179.981 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 15' ' ' ILE . . . . . 0.777 ' CD1' ' HB3' ' A' ' 11' ' ' LEU . 96.0 mt -53.82 -44.76 61.06 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.654 0 CA-C-N 115.183 -0.917 . . . . 0.0 110.69 -179.933 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 16' ' ' ILE . . . . . 0.939 HD12 HG12 ' A' ' 12' ' ' VAL . 96.7 mt -71.33 -36.15 60.39 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.697 0 CA-C-N 115.193 -0.912 . . . . 0.0 110.685 -179.984 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 17' ' ' ILE . . . . . 0.988 HG13 ' O ' ' A' ' 13' ' ' VAL . 96.7 mt -67.47 -46.85 82.49 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.795 0 CA-C-N 115.238 -0.892 . . . . 0.0 110.878 179.994 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -66.57 -56.14 12.14 Favored 'General case' 0 C--N 1.307 -1.264 0 CA-C-N 115.415 -0.811 . . . . 0.0 110.811 -179.95 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 19' ' ' ILE . . . . . 0.57 HD12 HG22 ' A' ' 15' ' ' ILE . 96.7 mt -51.84 -48.46 38.96 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.995 0 CA-C-N 115.303 -0.862 . . . . 0.0 110.761 -179.986 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 20' ' ' VAL . . . . . 0.72 HG23 ' O ' ' A' ' 16' ' ' ILE . 68.2 t -62.66 -46.69 95.74 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.898 0 CA-C-N 114.957 -1.02 . . . . 0.0 110.855 179.989 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 21' ' ' VAL . . . . . 0.823 HG23 ' O ' ' A' ' 17' ' ' ILE . 74.1 t -66.07 -56.4 14.88 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.114 0 CA-C-N 115.142 -0.935 . . . . 0.0 111.156 179.987 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 22' ' ' TRP . . . . . . . . . . . . . 90.3 t90 -52.29 -33.57 42.75 Favored 'General case' 0 C--N 1.306 -1.318 0 CA-C-N 114.808 -1.087 . . . . 0.0 111.007 179.95 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 48.5 t -69.32 -43.06 74.48 Favored 'General case' 0 N--CA 1.436 -1.139 0 CA-C-N 114.68 -1.145 . . . . 0.0 110.879 -179.94 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 24' ' ' ILE . . . . . 1.215 ' O ' HG23 ' A' ' 25' ' ' VAL . 96.7 mt -54.5 -46.57 71.4 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.342 0 CA-C-N 114.871 -1.059 . . . . 0.0 111.367 179.96 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 25' ' ' VAL . . . . . 1.215 HG23 ' O ' ' A' ' 24' ' ' ILE . 58.6 t . . . . . 0 C--N 1.295 -1.804 0 CA-C-N 115.226 -0.897 . . . . 0.0 109.803 -179.952 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.449 -0.491 0 N-CA-C 109.506 -0.553 . . . . 0.0 109.506 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 8' ' ' ILE . . . . . 0.452 ' O ' HG23 ' A' ' 12' ' ' VAL . 96.1 mt -52.4 -41.43 35.37 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 115.594 -0.73 . . . . 0.0 110.596 179.988 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 9' ' ' VAL . . . . . 0.449 ' O ' HG23 ' A' ' 13' ' ' VAL . 68.0 t -64.13 -46.0 94.88 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.315 0 CA-C-N 115.53 -0.759 . . . . 0.0 110.483 179.965 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -56.65 -47.15 80.4 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.602 -0.726 . . . . 0.0 110.569 -179.951 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 11' ' ' LEU . . . . . 0.783 ' HB3' ' CD1' ' A' ' 15' ' ' ILE . 77.1 mt -59.87 -49.43 77.71 Favored 'General case' 0 C--N 1.312 -1.036 0 CA-C-N 115.674 -0.694 . . . . 0.0 110.563 179.953 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 12' ' ' VAL . . . . . 0.938 HG12 HD12 ' A' ' 16' ' ' ILE . 68.0 t -55.93 -47.74 79.51 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.458 0 CA-C-N 116.101 -0.499 . . . . 0.0 110.664 -179.97 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 13' ' ' VAL . . . . . 1.003 ' O ' HG13 ' A' ' 17' ' ' ILE . 75.4 t -58.28 -55.6 21.35 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.547 0 CA-C-N 115.313 -0.858 . . . . 0.0 110.757 179.973 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -69.05 -50.83 45.02 Favored 'General case' 0 C--N 1.318 -0.792 0 CA-C-N 115.365 -0.834 . . . . 0.0 110.739 179.981 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 15' ' ' ILE . . . . . 0.783 ' CD1' ' HB3' ' A' ' 11' ' ' LEU . 96.0 mt -53.82 -44.76 61.06 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.654 0 CA-C-N 115.183 -0.917 . . . . 0.0 110.69 -179.933 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 16' ' ' ILE . . . . . 0.938 HD12 HG12 ' A' ' 12' ' ' VAL . 96.7 mt -71.33 -36.15 60.39 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.697 0 CA-C-N 115.193 -0.912 . . . . 0.0 110.685 -179.984 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 17' ' ' ILE . . . . . 1.003 HG13 ' O ' ' A' ' 13' ' ' VAL . 96.7 mt -67.47 -46.85 82.49 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.795 0 CA-C-N 115.238 -0.892 . . . . 0.0 110.878 179.994 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -66.57 -56.14 12.14 Favored 'General case' 0 C--N 1.307 -1.264 0 CA-C-N 115.415 -0.811 . . . . 0.0 110.811 -179.95 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 19' ' ' ILE . . . . . 0.587 HD12 HG22 ' A' ' 15' ' ' ILE . 96.7 mt -51.84 -48.46 38.96 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.995 0 CA-C-N 115.303 -0.862 . . . . 0.0 110.761 -179.986 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 20' ' ' VAL . . . . . 0.736 HG23 ' O ' ' A' ' 16' ' ' ILE . 68.2 t -62.66 -46.69 95.74 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.898 0 CA-C-N 114.957 -1.02 . . . . 0.0 110.855 179.989 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 21' ' ' VAL . . . . . 0.824 HG23 ' O ' ' A' ' 17' ' ' ILE . 74.1 t -66.07 -56.4 14.88 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.114 0 CA-C-N 115.142 -0.935 . . . . 0.0 111.156 179.987 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 22' ' ' TRP . . . . . . . . . . . . . 90.3 t90 -52.29 -33.57 42.75 Favored 'General case' 0 C--N 1.306 -1.318 0 CA-C-N 114.808 -1.087 . . . . 0.0 111.007 179.95 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 48.5 t -69.32 -43.06 74.48 Favored 'General case' 0 N--CA 1.436 -1.139 0 CA-C-N 114.68 -1.145 . . . . 0.0 110.879 -179.94 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 24' ' ' ILE . . . . . 1.201 ' O ' HG23 ' A' ' 25' ' ' VAL . 96.7 mt -54.5 -46.57 71.4 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.342 0 CA-C-N 114.871 -1.059 . . . . 0.0 111.367 179.96 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 25' ' ' VAL . . . . . 1.201 HG23 ' O ' ' A' ' 24' ' ' ILE . 58.6 t . . . . . 0 C--N 1.295 -1.804 0 CA-C-N 115.226 -0.897 . . . . 0.0 109.803 -179.952 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.449 -0.491 0 N-CA-C 109.506 -0.553 . . . . 0.0 109.506 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 8' ' ' ILE . . . . . 0.456 ' O ' HG23 ' A' ' 12' ' ' VAL . 96.1 mt -52.4 -41.43 35.37 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 115.594 -0.73 . . . . 0.0 110.596 179.988 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 9' ' ' VAL . . . . . 0.433 ' O ' HG23 ' A' ' 13' ' ' VAL . 68.0 t -64.13 -46.0 94.88 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.315 0 CA-C-N 115.53 -0.759 . . . . 0.0 110.483 179.965 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -56.65 -47.15 80.4 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.602 -0.726 . . . . 0.0 110.569 -179.951 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 11' ' ' LEU . . . . . 0.787 ' HB3' ' CD1' ' A' ' 15' ' ' ILE . 77.1 mt -59.87 -49.43 77.71 Favored 'General case' 0 C--N 1.312 -1.036 0 CA-C-N 115.674 -0.694 . . . . 0.0 110.563 179.953 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 12' ' ' VAL . . . . . 0.965 HG12 HD12 ' A' ' 16' ' ' ILE . 68.0 t -55.93 -47.74 79.51 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.458 0 CA-C-N 116.101 -0.499 . . . . 0.0 110.664 -179.97 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 13' ' ' VAL . . . . . 1.0 ' O ' HG13 ' A' ' 17' ' ' ILE . 75.4 t -58.28 -55.6 21.35 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.547 0 CA-C-N 115.313 -0.858 . . . . 0.0 110.757 179.973 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -69.05 -50.83 45.02 Favored 'General case' 0 C--N 1.318 -0.792 0 CA-C-N 115.365 -0.834 . . . . 0.0 110.739 179.981 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 15' ' ' ILE . . . . . 0.787 ' CD1' ' HB3' ' A' ' 11' ' ' LEU . 96.0 mt -53.82 -44.76 61.06 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.654 0 CA-C-N 115.183 -0.917 . . . . 0.0 110.69 -179.933 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 16' ' ' ILE . . . . . 0.965 HD12 HG12 ' A' ' 12' ' ' VAL . 96.7 mt -71.33 -36.15 60.39 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.697 0 CA-C-N 115.193 -0.912 . . . . 0.0 110.685 -179.984 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 17' ' ' ILE . . . . . 1.0 HG13 ' O ' ' A' ' 13' ' ' VAL . 96.7 mt -67.47 -46.85 82.49 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.795 0 CA-C-N 115.238 -0.892 . . . . 0.0 110.878 179.994 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -66.57 -56.14 12.14 Favored 'General case' 0 C--N 1.307 -1.264 0 CA-C-N 115.415 -0.811 . . . . 0.0 110.811 -179.95 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 19' ' ' ILE . . . . . 0.583 HD12 HG22 ' A' ' 15' ' ' ILE . 96.7 mt -51.84 -48.46 38.96 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.995 0 CA-C-N 115.303 -0.862 . . . . 0.0 110.761 -179.986 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 20' ' ' VAL . . . . . 0.725 HG23 ' O ' ' A' ' 16' ' ' ILE . 68.2 t -62.66 -46.69 95.74 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.898 0 CA-C-N 114.957 -1.02 . . . . 0.0 110.855 179.989 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 21' ' ' VAL . . . . . 0.809 HG23 ' O ' ' A' ' 17' ' ' ILE . 74.1 t -66.07 -56.4 14.88 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.114 0 CA-C-N 115.142 -0.935 . . . . 0.0 111.156 179.987 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 22' ' ' TRP . . . . . . . . . . . . . 90.3 t90 -52.29 -33.57 42.75 Favored 'General case' 0 C--N 1.306 -1.318 0 CA-C-N 114.808 -1.087 . . . . 0.0 111.007 179.95 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 48.5 t -69.32 -43.06 74.48 Favored 'General case' 0 N--CA 1.436 -1.139 0 CA-C-N 114.68 -1.145 . . . . 0.0 110.879 -179.94 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 24' ' ' ILE . . . . . 1.229 ' O ' HG23 ' A' ' 25' ' ' VAL . 96.7 mt -54.5 -46.57 71.4 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.342 0 CA-C-N 114.871 -1.059 . . . . 0.0 111.367 179.96 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 25' ' ' VAL . . . . . 1.229 HG23 ' O ' ' A' ' 24' ' ' ILE . 58.7 t . . . . . 0 C--N 1.295 -1.804 0 CA-C-N 115.226 -0.897 . . . . 0.0 109.794 -179.952 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.466 0 N-CA-C 109.525 -0.546 . . . . 0.0 109.525 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 8' ' ' ILE . . . . . 0.443 ' O ' HG23 ' A' ' 12' ' ' VAL . 96.1 mt -52.4 -41.43 35.37 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 115.594 -0.73 . . . . 0.0 110.596 179.988 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 9' ' ' VAL . . . . . 0.441 ' O ' HG23 ' A' ' 13' ' ' VAL . 68.0 t -64.13 -46.0 94.88 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.315 0 CA-C-N 115.53 -0.759 . . . . 0.0 110.483 179.965 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -56.65 -47.15 80.4 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.602 -0.726 . . . . 0.0 110.569 -179.951 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 11' ' ' LEU . . . . . 0.782 ' HB3' ' CD1' ' A' ' 15' ' ' ILE . 77.1 mt -59.87 -49.43 77.71 Favored 'General case' 0 C--N 1.312 -1.036 0 CA-C-N 115.674 -0.694 . . . . 0.0 110.563 179.953 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 12' ' ' VAL . . . . . 0.963 HG12 HD12 ' A' ' 16' ' ' ILE . 68.0 t -55.93 -47.74 79.51 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.458 0 CA-C-N 116.101 -0.499 . . . . 0.0 110.664 -179.97 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 13' ' ' VAL . . . . . 1.01 ' O ' HG13 ' A' ' 17' ' ' ILE . 75.4 t -58.28 -55.6 21.35 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.547 0 CA-C-N 115.313 -0.858 . . . . 0.0 110.757 179.973 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -69.05 -50.83 45.02 Favored 'General case' 0 C--N 1.318 -0.792 0 CA-C-N 115.365 -0.834 . . . . 0.0 110.739 179.981 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 15' ' ' ILE . . . . . 0.782 ' CD1' ' HB3' ' A' ' 11' ' ' LEU . 96.0 mt -53.82 -44.76 61.06 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.654 0 CA-C-N 115.183 -0.917 . . . . 0.0 110.69 -179.933 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 16' ' ' ILE . . . . . 0.963 HD12 HG12 ' A' ' 12' ' ' VAL . 96.7 mt -71.33 -36.15 60.39 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.697 0 CA-C-N 115.193 -0.912 . . . . 0.0 110.685 -179.984 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 17' ' ' ILE . . . . . 1.01 HG13 ' O ' ' A' ' 13' ' ' VAL . 96.7 mt -67.47 -46.85 82.49 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.795 0 CA-C-N 115.238 -0.892 . . . . 0.0 110.878 179.994 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -66.57 -56.14 12.14 Favored 'General case' 0 C--N 1.307 -1.264 0 CA-C-N 115.415 -0.811 . . . . 0.0 110.811 -179.95 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 19' ' ' ILE . . . . . 0.572 HD12 HG22 ' A' ' 15' ' ' ILE . 96.7 mt -51.84 -48.46 38.96 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.995 0 CA-C-N 115.303 -0.862 . . . . 0.0 110.761 -179.986 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 20' ' ' VAL . . . . . 0.729 HG23 ' O ' ' A' ' 16' ' ' ILE . 68.2 t -62.66 -46.69 95.74 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.898 0 CA-C-N 114.957 -1.02 . . . . 0.0 110.855 179.989 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 21' ' ' VAL . . . . . 0.822 HG23 ' O ' ' A' ' 17' ' ' ILE . 74.1 t -66.07 -56.4 14.88 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.114 0 CA-C-N 115.142 -0.935 . . . . 0.0 111.156 179.987 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 22' ' ' TRP . . . . . . . . . . . . . 90.3 t90 -52.29 -33.57 42.75 Favored 'General case' 0 C--N 1.306 -1.318 0 CA-C-N 114.808 -1.087 . . . . 0.0 111.007 179.95 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 48.5 t -69.32 -43.06 74.48 Favored 'General case' 0 N--CA 1.436 -1.139 0 CA-C-N 114.68 -1.145 . . . . 0.0 110.879 -179.94 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 24' ' ' ILE . . . . . 1.211 ' O ' HG23 ' A' ' 25' ' ' VAL . 96.7 mt -54.5 -46.57 71.4 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.342 0 CA-C-N 114.871 -1.059 . . . . 0.0 111.367 179.96 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 25' ' ' VAL . . . . . 1.211 HG23 ' O ' ' A' ' 24' ' ' ILE . 58.7 t . . . . . 0 C--N 1.295 -1.804 0 CA-C-N 115.226 -0.897 . . . . 0.0 109.801 -179.952 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.466 0 N-CA-C 109.525 -0.546 . . . . 0.0 109.525 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 8' ' ' ILE . . . . . 0.446 ' O ' HG23 ' A' ' 12' ' ' VAL . 96.1 mt -52.4 -41.43 35.37 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 115.594 -0.73 . . . . 0.0 110.596 179.988 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . 0.441 ' O ' HG23 ' A' ' 13' ' ' VAL . 68.0 t -64.13 -46.0 94.88 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.315 0 CA-C-N 115.53 -0.759 . . . . 0.0 110.483 179.965 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -56.65 -47.15 80.4 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.602 -0.726 . . . . 0.0 110.569 -179.951 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . 0.777 ' HB3' ' CD1' ' A' ' 15' ' ' ILE . 77.1 mt -59.87 -49.43 77.71 Favored 'General case' 0 C--N 1.312 -1.036 0 CA-C-N 115.674 -0.694 . . . . 0.0 110.563 179.953 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . 0.939 HG12 HD12 ' A' ' 16' ' ' ILE . 68.0 t -55.93 -47.74 79.51 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.458 0 CA-C-N 116.101 -0.499 . . . . 0.0 110.664 -179.97 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . 0.988 ' O ' HG13 ' A' ' 17' ' ' ILE . 75.4 t -58.28 -55.6 21.35 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.547 0 CA-C-N 115.313 -0.858 . . . . 0.0 110.757 179.973 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -69.05 -50.83 45.02 Favored 'General case' 0 C--N 1.318 -0.792 0 CA-C-N 115.365 -0.834 . . . . 0.0 110.739 179.981 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 15' ' ' ILE . . . . . 0.777 ' CD1' ' HB3' ' A' ' 11' ' ' LEU . 96.0 mt -53.82 -44.76 61.06 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.654 0 CA-C-N 115.183 -0.917 . . . . 0.0 110.69 -179.933 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 16' ' ' ILE . . . . . 0.939 HD12 HG12 ' A' ' 12' ' ' VAL . 96.7 mt -71.33 -36.15 60.39 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.697 0 CA-C-N 115.193 -0.912 . . . . 0.0 110.685 -179.984 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 17' ' ' ILE . . . . . 0.988 HG13 ' O ' ' A' ' 13' ' ' VAL . 96.7 mt -67.47 -46.85 82.49 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.795 0 CA-C-N 115.238 -0.892 . . . . 0.0 110.878 179.994 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -66.57 -56.14 12.14 Favored 'General case' 0 C--N 1.307 -1.264 0 CA-C-N 115.415 -0.811 . . . . 0.0 110.811 -179.95 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 19' ' ' ILE . . . . . 0.57 HD12 HG22 ' A' ' 15' ' ' ILE . 96.7 mt -51.84 -48.46 38.96 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.995 0 CA-C-N 115.303 -0.862 . . . . 0.0 110.761 -179.986 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . 0.72 HG23 ' O ' ' A' ' 16' ' ' ILE . 68.2 t -62.66 -46.69 95.74 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.898 0 CA-C-N 114.957 -1.02 . . . . 0.0 110.855 179.989 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . 0.823 HG23 ' O ' ' A' ' 17' ' ' ILE . 74.1 t -66.07 -56.4 14.88 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.114 0 CA-C-N 115.142 -0.935 . . . . 0.0 111.156 179.987 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 22' ' ' TRP . . . . . . . . . . . . . 90.3 t90 -52.29 -33.57 42.75 Favored 'General case' 0 C--N 1.306 -1.318 0 CA-C-N 114.808 -1.087 . . . . 0.0 111.007 179.95 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 48.5 t -69.32 -43.06 74.48 Favored 'General case' 0 N--CA 1.436 -1.139 0 CA-C-N 114.68 -1.145 . . . . 0.0 110.879 -179.94 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . 1.215 ' O ' HG23 ' A' ' 25' ' ' VAL . 96.7 mt -54.5 -46.57 71.4 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.342 0 CA-C-N 114.871 -1.059 . . . . 0.0 111.367 179.96 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . 1.215 HG23 ' O ' ' A' ' 24' ' ' ILE . 58.6 t . . . . . 0 C--N 1.295 -1.804 0 CA-C-N 115.226 -0.897 . . . . 0.0 109.803 -179.952 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.449 -0.491 0 N-CA-C 109.506 -0.553 . . . . 0.0 109.506 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 8' ' ' ILE . . . . . 0.452 ' O ' HG23 ' A' ' 12' ' ' VAL . 96.1 mt -52.4 -41.43 35.37 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 115.594 -0.73 . . . . 0.0 110.596 179.988 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . 0.449 ' O ' HG23 ' A' ' 13' ' ' VAL . 68.0 t -64.13 -46.0 94.88 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.315 0 CA-C-N 115.53 -0.759 . . . . 0.0 110.483 179.965 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -56.65 -47.15 80.4 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.602 -0.726 . . . . 0.0 110.569 -179.951 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . 0.783 ' HB3' ' CD1' ' A' ' 15' ' ' ILE . 77.1 mt -59.87 -49.43 77.71 Favored 'General case' 0 C--N 1.312 -1.036 0 CA-C-N 115.674 -0.694 . . . . 0.0 110.563 179.953 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . 0.938 HG12 HD12 ' A' ' 16' ' ' ILE . 68.0 t -55.93 -47.74 79.51 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.458 0 CA-C-N 116.101 -0.499 . . . . 0.0 110.664 -179.97 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . 1.003 ' O ' HG13 ' A' ' 17' ' ' ILE . 75.4 t -58.28 -55.6 21.35 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.547 0 CA-C-N 115.313 -0.858 . . . . 0.0 110.757 179.973 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -69.05 -50.83 45.02 Favored 'General case' 0 C--N 1.318 -0.792 0 CA-C-N 115.365 -0.834 . . . . 0.0 110.739 179.981 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 15' ' ' ILE . . . . . 0.783 ' CD1' ' HB3' ' A' ' 11' ' ' LEU . 96.0 mt -53.82 -44.76 61.06 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.654 0 CA-C-N 115.183 -0.917 . . . . 0.0 110.69 -179.933 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 16' ' ' ILE . . . . . 0.938 HD12 HG12 ' A' ' 12' ' ' VAL . 96.7 mt -71.33 -36.15 60.39 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.697 0 CA-C-N 115.193 -0.912 . . . . 0.0 110.685 -179.984 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 17' ' ' ILE . . . . . 1.003 HG13 ' O ' ' A' ' 13' ' ' VAL . 96.7 mt -67.47 -46.85 82.49 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.795 0 CA-C-N 115.238 -0.892 . . . . 0.0 110.878 179.994 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -66.57 -56.14 12.14 Favored 'General case' 0 C--N 1.307 -1.264 0 CA-C-N 115.415 -0.811 . . . . 0.0 110.811 -179.95 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 19' ' ' ILE . . . . . 0.587 HD12 HG22 ' A' ' 15' ' ' ILE . 96.7 mt -51.84 -48.46 38.96 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.995 0 CA-C-N 115.303 -0.862 . . . . 0.0 110.761 -179.986 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . 0.736 HG23 ' O ' ' A' ' 16' ' ' ILE . 68.2 t -62.66 -46.69 95.74 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.898 0 CA-C-N 114.957 -1.02 . . . . 0.0 110.855 179.989 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . 0.824 HG23 ' O ' ' A' ' 17' ' ' ILE . 74.1 t -66.07 -56.4 14.88 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.114 0 CA-C-N 115.142 -0.935 . . . . 0.0 111.156 179.987 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 22' ' ' TRP . . . . . . . . . . . . . 90.3 t90 -52.29 -33.57 42.75 Favored 'General case' 0 C--N 1.306 -1.318 0 CA-C-N 114.808 -1.087 . . . . 0.0 111.007 179.95 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 48.5 t -69.32 -43.06 74.48 Favored 'General case' 0 N--CA 1.436 -1.139 0 CA-C-N 114.68 -1.145 . . . . 0.0 110.879 -179.94 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . 1.201 ' O ' HG23 ' A' ' 25' ' ' VAL . 96.7 mt -54.5 -46.57 71.4 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.342 0 CA-C-N 114.871 -1.059 . . . . 0.0 111.367 179.96 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . 1.201 HG23 ' O ' ' A' ' 24' ' ' ILE . 58.6 t . . . . . 0 C--N 1.295 -1.804 0 CA-C-N 115.226 -0.897 . . . . 0.0 109.803 -179.952 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.449 -0.491 0 N-CA-C 109.506 -0.553 . . . . 0.0 109.506 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 8' ' ' ILE . . . . . 0.456 ' O ' HG23 ' A' ' 12' ' ' VAL . 96.1 mt -52.4 -41.43 35.37 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 115.594 -0.73 . . . . 0.0 110.596 179.988 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . 0.433 ' O ' HG23 ' A' ' 13' ' ' VAL . 68.0 t -64.13 -46.0 94.88 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.315 0 CA-C-N 115.53 -0.759 . . . . 0.0 110.483 179.965 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -56.65 -47.15 80.4 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.602 -0.726 . . . . 0.0 110.569 -179.951 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . 0.787 ' HB3' ' CD1' ' A' ' 15' ' ' ILE . 77.1 mt -59.87 -49.43 77.71 Favored 'General case' 0 C--N 1.312 -1.036 0 CA-C-N 115.674 -0.694 . . . . 0.0 110.563 179.953 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . 0.965 HG12 HD12 ' A' ' 16' ' ' ILE . 68.0 t -55.93 -47.74 79.51 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.458 0 CA-C-N 116.101 -0.499 . . . . 0.0 110.664 -179.97 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . 1.0 ' O ' HG13 ' A' ' 17' ' ' ILE . 75.4 t -58.28 -55.6 21.35 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.547 0 CA-C-N 115.313 -0.858 . . . . 0.0 110.757 179.973 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -69.05 -50.83 45.02 Favored 'General case' 0 C--N 1.318 -0.792 0 CA-C-N 115.365 -0.834 . . . . 0.0 110.739 179.981 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 15' ' ' ILE . . . . . 0.787 ' CD1' ' HB3' ' A' ' 11' ' ' LEU . 96.0 mt -53.82 -44.76 61.06 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.654 0 CA-C-N 115.183 -0.917 . . . . 0.0 110.69 -179.933 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 16' ' ' ILE . . . . . 0.965 HD12 HG12 ' A' ' 12' ' ' VAL . 96.7 mt -71.33 -36.15 60.39 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.697 0 CA-C-N 115.193 -0.912 . . . . 0.0 110.685 -179.984 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 17' ' ' ILE . . . . . 1.0 HG13 ' O ' ' A' ' 13' ' ' VAL . 96.7 mt -67.47 -46.85 82.49 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.795 0 CA-C-N 115.238 -0.892 . . . . 0.0 110.878 179.994 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -66.57 -56.14 12.14 Favored 'General case' 0 C--N 1.307 -1.264 0 CA-C-N 115.415 -0.811 . . . . 0.0 110.811 -179.95 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 19' ' ' ILE . . . . . 0.583 HD12 HG22 ' A' ' 15' ' ' ILE . 96.7 mt -51.84 -48.46 38.96 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.995 0 CA-C-N 115.303 -0.862 . . . . 0.0 110.761 -179.986 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . 0.725 HG23 ' O ' ' A' ' 16' ' ' ILE . 68.2 t -62.66 -46.69 95.74 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.898 0 CA-C-N 114.957 -1.02 . . . . 0.0 110.855 179.989 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . 0.809 HG23 ' O ' ' A' ' 17' ' ' ILE . 74.1 t -66.07 -56.4 14.88 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.114 0 CA-C-N 115.142 -0.935 . . . . 0.0 111.156 179.987 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 22' ' ' TRP . . . . . . . . . . . . . 90.3 t90 -52.29 -33.57 42.75 Favored 'General case' 0 C--N 1.306 -1.318 0 CA-C-N 114.808 -1.087 . . . . 0.0 111.007 179.95 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 48.5 t -69.32 -43.06 74.48 Favored 'General case' 0 N--CA 1.436 -1.139 0 CA-C-N 114.68 -1.145 . . . . 0.0 110.879 -179.94 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . 1.229 ' O ' HG23 ' A' ' 25' ' ' VAL . 96.7 mt -54.5 -46.57 71.4 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.342 0 CA-C-N 114.871 -1.059 . . . . 0.0 111.367 179.96 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . 1.229 HG23 ' O ' ' A' ' 24' ' ' ILE . 58.7 t . . . . . 0 C--N 1.295 -1.804 0 CA-C-N 115.226 -0.897 . . . . 0.0 109.794 -179.952 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.466 0 N-CA-C 109.525 -0.546 . . . . 0.0 109.525 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 8' ' ' ILE . . . . . 0.443 ' O ' HG23 ' A' ' 12' ' ' VAL . 96.1 mt -52.4 -41.43 35.37 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 115.594 -0.73 . . . . 0.0 110.596 179.988 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . 0.441 ' O ' HG23 ' A' ' 13' ' ' VAL . 68.0 t -64.13 -46.0 94.88 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.315 0 CA-C-N 115.53 -0.759 . . . . 0.0 110.483 179.965 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -56.65 -47.15 80.4 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.602 -0.726 . . . . 0.0 110.569 -179.951 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . 0.782 ' HB3' ' CD1' ' A' ' 15' ' ' ILE . 77.1 mt -59.87 -49.43 77.71 Favored 'General case' 0 C--N 1.312 -1.036 0 CA-C-N 115.674 -0.694 . . . . 0.0 110.563 179.953 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . 0.963 HG12 HD12 ' A' ' 16' ' ' ILE . 68.0 t -55.93 -47.74 79.51 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.458 0 CA-C-N 116.101 -0.499 . . . . 0.0 110.664 -179.97 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . 1.01 ' O ' HG13 ' A' ' 17' ' ' ILE . 75.4 t -58.28 -55.6 21.35 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.547 0 CA-C-N 115.313 -0.858 . . . . 0.0 110.757 179.973 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -69.05 -50.83 45.02 Favored 'General case' 0 C--N 1.318 -0.792 0 CA-C-N 115.365 -0.834 . . . . 0.0 110.739 179.981 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 15' ' ' ILE . . . . . 0.782 ' CD1' ' HB3' ' A' ' 11' ' ' LEU . 96.0 mt -53.82 -44.76 61.06 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.654 0 CA-C-N 115.183 -0.917 . . . . 0.0 110.69 -179.933 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 16' ' ' ILE . . . . . 0.963 HD12 HG12 ' A' ' 12' ' ' VAL . 96.7 mt -71.33 -36.15 60.39 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.697 0 CA-C-N 115.193 -0.912 . . . . 0.0 110.685 -179.984 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 17' ' ' ILE . . . . . 1.01 HG13 ' O ' ' A' ' 13' ' ' VAL . 96.7 mt -67.47 -46.85 82.49 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.795 0 CA-C-N 115.238 -0.892 . . . . 0.0 110.878 179.994 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -66.57 -56.14 12.14 Favored 'General case' 0 C--N 1.307 -1.264 0 CA-C-N 115.415 -0.811 . . . . 0.0 110.811 -179.95 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 19' ' ' ILE . . . . . 0.572 HD12 HG22 ' A' ' 15' ' ' ILE . 96.7 mt -51.84 -48.46 38.96 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.995 0 CA-C-N 115.303 -0.862 . . . . 0.0 110.761 -179.986 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . 0.729 HG23 ' O ' ' A' ' 16' ' ' ILE . 68.2 t -62.66 -46.69 95.74 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.898 0 CA-C-N 114.957 -1.02 . . . . 0.0 110.855 179.989 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . 0.822 HG23 ' O ' ' A' ' 17' ' ' ILE . 74.1 t -66.07 -56.4 14.88 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.114 0 CA-C-N 115.142 -0.935 . . . . 0.0 111.156 179.987 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 22' ' ' TRP . . . . . . . . . . . . . 90.3 t90 -52.29 -33.57 42.75 Favored 'General case' 0 C--N 1.306 -1.318 0 CA-C-N 114.808 -1.087 . . . . 0.0 111.007 179.95 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 48.5 t -69.32 -43.06 74.48 Favored 'General case' 0 N--CA 1.436 -1.139 0 CA-C-N 114.68 -1.145 . . . . 0.0 110.879 -179.94 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . 1.211 ' O ' HG23 ' A' ' 25' ' ' VAL . 96.7 mt -54.5 -46.57 71.4 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.342 0 CA-C-N 114.871 -1.059 . . . . 0.0 111.367 179.96 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . 1.211 HG23 ' O ' ' A' ' 24' ' ' ILE . 58.7 t . . . . . 0 C--N 1.295 -1.804 0 CA-C-N 115.226 -0.897 . . . . 0.0 109.801 -179.952 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.466 0 N-CA-C 109.525 -0.546 . . . . 0.0 109.525 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . 0.446 ' O ' HG23 ' A' ' 12' ' ' VAL . 96.1 mt -52.4 -41.43 35.37 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 115.594 -0.73 . . . . 0.0 110.596 179.988 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . 0.441 ' O ' HG23 ' A' ' 13' ' ' VAL . 68.0 t -64.13 -46.0 94.88 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.315 0 CA-C-N 115.53 -0.759 . . . . 0.0 110.483 179.965 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -56.65 -47.15 80.4 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.602 -0.726 . . . . 0.0 110.569 -179.951 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . 0.777 ' HB3' ' CD1' ' A' ' 15' ' ' ILE . 77.1 mt -59.87 -49.43 77.71 Favored 'General case' 0 C--N 1.312 -1.036 0 CA-C-N 115.674 -0.694 . . . . 0.0 110.563 179.953 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . 0.939 HG12 HD12 ' A' ' 16' ' ' ILE . 68.0 t -55.93 -47.74 79.51 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.458 0 CA-C-N 116.101 -0.499 . . . . 0.0 110.664 -179.97 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . 0.988 ' O ' HG13 ' A' ' 17' ' ' ILE . 75.4 t -58.28 -55.6 21.35 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.547 0 CA-C-N 115.313 -0.858 . . . . 0.0 110.757 179.973 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -69.05 -50.83 45.02 Favored 'General case' 0 C--N 1.318 -0.792 0 CA-C-N 115.365 -0.834 . . . . 0.0 110.739 179.981 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . 0.777 ' CD1' ' HB3' ' A' ' 11' ' ' LEU . 96.0 mt -53.82 -44.76 61.06 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.654 0 CA-C-N 115.183 -0.917 . . . . 0.0 110.69 -179.933 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 16' ' ' ILE . . . . . 0.939 HD12 HG12 ' A' ' 12' ' ' VAL . 96.7 mt -71.33 -36.15 60.39 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.697 0 CA-C-N 115.193 -0.912 . . . . 0.0 110.685 -179.984 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 17' ' ' ILE . . . . . 0.988 HG13 ' O ' ' A' ' 13' ' ' VAL . 96.7 mt -67.47 -46.85 82.49 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.795 0 CA-C-N 115.238 -0.892 . . . . 0.0 110.878 179.994 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -66.57 -56.14 12.14 Favored 'General case' 0 C--N 1.307 -1.264 0 CA-C-N 115.415 -0.811 . . . . 0.0 110.811 -179.95 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' ILE . . . . . 0.57 HD12 HG22 ' A' ' 15' ' ' ILE . 96.7 mt -51.84 -48.46 38.96 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.995 0 CA-C-N 115.303 -0.862 . . . . 0.0 110.761 -179.986 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . 0.72 HG23 ' O ' ' A' ' 16' ' ' ILE . 68.2 t -62.66 -46.69 95.74 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.898 0 CA-C-N 114.957 -1.02 . . . . 0.0 110.855 179.989 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . 0.823 HG23 ' O ' ' A' ' 17' ' ' ILE . 74.1 t -66.07 -56.4 14.88 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.114 0 CA-C-N 115.142 -0.935 . . . . 0.0 111.156 179.987 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 22' ' ' TRP . . . . . . . . . . . . . 90.3 t90 -52.29 -33.57 42.75 Favored 'General case' 0 C--N 1.306 -1.318 0 CA-C-N 114.808 -1.087 . . . . 0.0 111.007 179.95 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 48.5 t -69.32 -43.06 74.48 Favored 'General case' 0 N--CA 1.436 -1.139 0 CA-C-N 114.68 -1.145 . . . . 0.0 110.879 -179.94 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . 1.215 ' O ' HG23 ' A' ' 25' ' ' VAL . 96.7 mt -54.5 -46.57 71.4 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.342 0 CA-C-N 114.871 -1.059 . . . . 0.0 111.367 179.96 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . 1.215 HG23 ' O ' ' A' ' 24' ' ' ILE . 58.6 t . . . . . 0 C--N 1.295 -1.804 0 CA-C-N 115.226 -0.897 . . . . 0.0 109.803 -179.952 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.449 -0.491 0 N-CA-C 109.506 -0.553 . . . . 0.0 109.506 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . 0.452 ' O ' HG23 ' A' ' 12' ' ' VAL . 96.1 mt -52.4 -41.43 35.37 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 115.594 -0.73 . . . . 0.0 110.596 179.988 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . 0.449 ' O ' HG23 ' A' ' 13' ' ' VAL . 68.0 t -64.13 -46.0 94.88 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.315 0 CA-C-N 115.53 -0.759 . . . . 0.0 110.483 179.965 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -56.65 -47.15 80.4 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.602 -0.726 . . . . 0.0 110.569 -179.951 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . 0.783 ' HB3' ' CD1' ' A' ' 15' ' ' ILE . 77.1 mt -59.87 -49.43 77.71 Favored 'General case' 0 C--N 1.312 -1.036 0 CA-C-N 115.674 -0.694 . . . . 0.0 110.563 179.953 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . 0.938 HG12 HD12 ' A' ' 16' ' ' ILE . 68.0 t -55.93 -47.74 79.51 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.458 0 CA-C-N 116.101 -0.499 . . . . 0.0 110.664 -179.97 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . 1.003 ' O ' HG13 ' A' ' 17' ' ' ILE . 75.4 t -58.28 -55.6 21.35 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.547 0 CA-C-N 115.313 -0.858 . . . . 0.0 110.757 179.973 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -69.05 -50.83 45.02 Favored 'General case' 0 C--N 1.318 -0.792 0 CA-C-N 115.365 -0.834 . . . . 0.0 110.739 179.981 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . 0.783 ' CD1' ' HB3' ' A' ' 11' ' ' LEU . 96.0 mt -53.82 -44.76 61.06 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.654 0 CA-C-N 115.183 -0.917 . . . . 0.0 110.69 -179.933 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 16' ' ' ILE . . . . . 0.938 HD12 HG12 ' A' ' 12' ' ' VAL . 96.7 mt -71.33 -36.15 60.39 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.697 0 CA-C-N 115.193 -0.912 . . . . 0.0 110.685 -179.984 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 17' ' ' ILE . . . . . 1.003 HG13 ' O ' ' A' ' 13' ' ' VAL . 96.7 mt -67.47 -46.85 82.49 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.795 0 CA-C-N 115.238 -0.892 . . . . 0.0 110.878 179.994 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -66.57 -56.14 12.14 Favored 'General case' 0 C--N 1.307 -1.264 0 CA-C-N 115.415 -0.811 . . . . 0.0 110.811 -179.95 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 19' ' ' ILE . . . . . 0.587 HD12 HG22 ' A' ' 15' ' ' ILE . 96.7 mt -51.84 -48.46 38.96 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.995 0 CA-C-N 115.303 -0.862 . . . . 0.0 110.761 -179.986 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . 0.736 HG23 ' O ' ' A' ' 16' ' ' ILE . 68.2 t -62.66 -46.69 95.74 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.898 0 CA-C-N 114.957 -1.02 . . . . 0.0 110.855 179.989 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . 0.824 HG23 ' O ' ' A' ' 17' ' ' ILE . 74.1 t -66.07 -56.4 14.88 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.114 0 CA-C-N 115.142 -0.935 . . . . 0.0 111.156 179.987 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 22' ' ' TRP . . . . . . . . . . . . . 90.3 t90 -52.29 -33.57 42.75 Favored 'General case' 0 C--N 1.306 -1.318 0 CA-C-N 114.808 -1.087 . . . . 0.0 111.007 179.95 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 48.5 t -69.32 -43.06 74.48 Favored 'General case' 0 N--CA 1.436 -1.139 0 CA-C-N 114.68 -1.145 . . . . 0.0 110.879 -179.94 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . 1.201 ' O ' HG23 ' A' ' 25' ' ' VAL . 96.7 mt -54.5 -46.57 71.4 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.342 0 CA-C-N 114.871 -1.059 . . . . 0.0 111.367 179.96 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . 1.201 HG23 ' O ' ' A' ' 24' ' ' ILE . 58.6 t . . . . . 0 C--N 1.295 -1.804 0 CA-C-N 115.226 -0.897 . . . . 0.0 109.803 -179.952 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.449 -0.491 0 N-CA-C 109.506 -0.553 . . . . 0.0 109.506 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . 0.456 ' O ' HG23 ' A' ' 12' ' ' VAL . 96.1 mt -52.4 -41.43 35.37 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 115.594 -0.73 . . . . 0.0 110.596 179.988 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . 0.433 ' O ' HG23 ' A' ' 13' ' ' VAL . 68.0 t -64.13 -46.0 94.88 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.315 0 CA-C-N 115.53 -0.759 . . . . 0.0 110.483 179.965 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -56.65 -47.15 80.4 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.602 -0.726 . . . . 0.0 110.569 -179.951 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . 0.787 ' HB3' ' CD1' ' A' ' 15' ' ' ILE . 77.1 mt -59.87 -49.43 77.71 Favored 'General case' 0 C--N 1.312 -1.036 0 CA-C-N 115.674 -0.694 . . . . 0.0 110.563 179.953 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . 0.965 HG12 HD12 ' A' ' 16' ' ' ILE . 68.0 t -55.93 -47.74 79.51 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.458 0 CA-C-N 116.101 -0.499 . . . . 0.0 110.664 -179.97 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . 1.0 ' O ' HG13 ' A' ' 17' ' ' ILE . 75.4 t -58.28 -55.6 21.35 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.547 0 CA-C-N 115.313 -0.858 . . . . 0.0 110.757 179.973 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -69.05 -50.83 45.02 Favored 'General case' 0 C--N 1.318 -0.792 0 CA-C-N 115.365 -0.834 . . . . 0.0 110.739 179.981 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . 0.787 ' CD1' ' HB3' ' A' ' 11' ' ' LEU . 96.0 mt -53.82 -44.76 61.06 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.654 0 CA-C-N 115.183 -0.917 . . . . 0.0 110.69 -179.933 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 16' ' ' ILE . . . . . 0.965 HD12 HG12 ' A' ' 12' ' ' VAL . 96.7 mt -71.33 -36.15 60.39 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.697 0 CA-C-N 115.193 -0.912 . . . . 0.0 110.685 -179.984 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 17' ' ' ILE . . . . . 1.0 HG13 ' O ' ' A' ' 13' ' ' VAL . 96.7 mt -67.47 -46.85 82.49 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.795 0 CA-C-N 115.238 -0.892 . . . . 0.0 110.878 179.994 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -66.57 -56.14 12.14 Favored 'General case' 0 C--N 1.307 -1.264 0 CA-C-N 115.415 -0.811 . . . . 0.0 110.811 -179.95 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 19' ' ' ILE . . . . . 0.583 HD12 HG22 ' A' ' 15' ' ' ILE . 96.7 mt -51.84 -48.46 38.96 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.995 0 CA-C-N 115.303 -0.862 . . . . 0.0 110.761 -179.986 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . 0.725 HG23 ' O ' ' A' ' 16' ' ' ILE . 68.2 t -62.66 -46.69 95.74 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.898 0 CA-C-N 114.957 -1.02 . . . . 0.0 110.855 179.989 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . 0.809 HG23 ' O ' ' A' ' 17' ' ' ILE . 74.1 t -66.07 -56.4 14.88 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.114 0 CA-C-N 115.142 -0.935 . . . . 0.0 111.156 179.987 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 22' ' ' TRP . . . . . . . . . . . . . 90.3 t90 -52.29 -33.57 42.75 Favored 'General case' 0 C--N 1.306 -1.318 0 CA-C-N 114.808 -1.087 . . . . 0.0 111.007 179.95 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 48.5 t -69.32 -43.06 74.48 Favored 'General case' 0 N--CA 1.436 -1.139 0 CA-C-N 114.68 -1.145 . . . . 0.0 110.879 -179.94 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . 1.229 ' O ' HG23 ' A' ' 25' ' ' VAL . 96.7 mt -54.5 -46.57 71.4 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.342 0 CA-C-N 114.871 -1.059 . . . . 0.0 111.367 179.96 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . 1.229 HG23 ' O ' ' A' ' 24' ' ' ILE . 58.7 t . . . . . 0 C--N 1.295 -1.804 0 CA-C-N 115.226 -0.897 . . . . 0.0 109.794 -179.952 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.466 0 N-CA-C 109.525 -0.546 . . . . 0.0 109.525 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . 0.443 ' O ' HG23 ' A' ' 12' ' ' VAL . 96.1 mt -52.4 -41.43 35.37 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 115.594 -0.73 . . . . 0.0 110.596 179.988 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . 0.441 ' O ' HG23 ' A' ' 13' ' ' VAL . 68.0 t -64.13 -46.0 94.88 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.315 0 CA-C-N 115.53 -0.759 . . . . 0.0 110.483 179.965 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -56.65 -47.15 80.4 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.602 -0.726 . . . . 0.0 110.569 -179.951 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . 0.782 ' HB3' ' CD1' ' A' ' 15' ' ' ILE . 77.1 mt -59.87 -49.43 77.71 Favored 'General case' 0 C--N 1.312 -1.036 0 CA-C-N 115.674 -0.694 . . . . 0.0 110.563 179.953 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . 0.963 HG12 HD12 ' A' ' 16' ' ' ILE . 68.0 t -55.93 -47.74 79.51 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.458 0 CA-C-N 116.101 -0.499 . . . . 0.0 110.664 -179.97 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . 1.01 ' O ' HG13 ' A' ' 17' ' ' ILE . 75.4 t -58.28 -55.6 21.35 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.547 0 CA-C-N 115.313 -0.858 . . . . 0.0 110.757 179.973 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -69.05 -50.83 45.02 Favored 'General case' 0 C--N 1.318 -0.792 0 CA-C-N 115.365 -0.834 . . . . 0.0 110.739 179.981 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . 0.782 ' CD1' ' HB3' ' A' ' 11' ' ' LEU . 96.0 mt -53.82 -44.76 61.06 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.654 0 CA-C-N 115.183 -0.917 . . . . 0.0 110.69 -179.933 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 16' ' ' ILE . . . . . 0.963 HD12 HG12 ' A' ' 12' ' ' VAL . 96.7 mt -71.33 -36.15 60.39 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.697 0 CA-C-N 115.193 -0.912 . . . . 0.0 110.685 -179.984 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 17' ' ' ILE . . . . . 1.01 HG13 ' O ' ' A' ' 13' ' ' VAL . 96.7 mt -67.47 -46.85 82.49 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.795 0 CA-C-N 115.238 -0.892 . . . . 0.0 110.878 179.994 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -66.57 -56.14 12.14 Favored 'General case' 0 C--N 1.307 -1.264 0 CA-C-N 115.415 -0.811 . . . . 0.0 110.811 -179.95 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 19' ' ' ILE . . . . . 0.572 HD12 HG22 ' A' ' 15' ' ' ILE . 96.7 mt -51.84 -48.46 38.96 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.995 0 CA-C-N 115.303 -0.862 . . . . 0.0 110.761 -179.986 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . 0.729 HG23 ' O ' ' A' ' 16' ' ' ILE . 68.2 t -62.66 -46.69 95.74 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.898 0 CA-C-N 114.957 -1.02 . . . . 0.0 110.855 179.989 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . 0.822 HG23 ' O ' ' A' ' 17' ' ' ILE . 74.1 t -66.07 -56.4 14.88 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.114 0 CA-C-N 115.142 -0.935 . . . . 0.0 111.156 179.987 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 22' ' ' TRP . . . . . . . . . . . . . 90.3 t90 -52.29 -33.57 42.75 Favored 'General case' 0 C--N 1.306 -1.318 0 CA-C-N 114.808 -1.087 . . . . 0.0 111.007 179.95 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 48.5 t -69.32 -43.06 74.48 Favored 'General case' 0 N--CA 1.436 -1.139 0 CA-C-N 114.68 -1.145 . . . . 0.0 110.879 -179.94 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . 1.211 ' O ' HG23 ' A' ' 25' ' ' VAL . 96.7 mt -54.5 -46.57 71.4 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.342 0 CA-C-N 114.871 -1.059 . . . . 0.0 111.367 179.96 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . 1.211 HG23 ' O ' ' A' ' 24' ' ' ILE . 58.7 t . . . . . 0 C--N 1.295 -1.804 0 CA-C-N 115.226 -0.897 . . . . 0.0 109.801 -179.952 . . . . . . . . 1 1 . 1 stop_ save_